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bilirubin by biliverdin reductase. HO-1, an important enzyme with antioxidant and cytoprotective 
properties, functions against oxidative stress generated in response to heme and to various stress stimuli, 
such as zinc. The cytoprotective function of HO-1 is dependent on both the activities of the reaction 
products and on the inducibility of the heme oxygenase gene (hmox-1), which is regulated primarily at 
the level of gene transcription by two distal enhancers, E1 and E2. Characterization of the enhancers led 
to the identification of multiple stress response elements (StREs) that are necessary and sufficient for 
hmox-1 gene regulation by almost all inducers tested. Studies from this laboratory identified Nrf-2 as a 
dominant regulator that mediates activation of hmox-1 via the StRE motifs by several inducers, 
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Findings suggest ERK1 plays an important role in inducer-dependent regulation of hmox-1 by zinc 
through its action (phosphorylation of Nrf-2 and cooperation between the StRE and Nrf-2 induce hmox-
1). In conclusion, targeting Nrf-2-ERK1 individually or together allows for controlled regulation of 
hmox-1 expression and illuminates new avenues of research and strategies for therapeutic intervention 




























1.1 Zinc and the Environment 
Humans are exposed to zinc from numerous industrial and environmental sources, mainly 
through ingestion. In industry, zinc is used in steel coating and in making dry batteries. Zinc, as a 
pollutant from industry, exists in two forms: as solid dust and in water. We ingest zinc into our 
bodies through drinking water and eating seafood (King and Keen, 1999; Lonnerdal, 2000). 
Ingested, or absorbed, zinc is stored in soft tissues, especially in the liver and kidney (Ho and 
Ames, 2002). The recommended daily allowance (RDA) of zinc is 15 milligrams/day for males 
and 12 milligrams/day for females (King and Keen, 1999). 
It is well known that micronutrients in the diet, such as zinc, can influence human 
development. Zinc deficiency can lead to immune-suppression, delayed sexual maturation, and 
poor vision. Increased levels of zinc can lead to anemia because of harmful effects on red blood 
cells (Berg and Shi, 1996; Salgueiro et al., 2000). Also, exposure to zinc in the workplace 
contributes to progression of renal diseases (Wittman, and Hu 2002) 
1.2 Effects of Zinc on DNA Repair 
Recent studies have demonstrated that ultraviolet (UV) radiation exposure increases 
production of reactive oxygen species, which has harmful effects on the skin. The defense 
mechanism that humans have developed is to  a pathway in which glutathione, selenium, and 
zinc are utilized in the cellular action against oxidative damage by UV. Thiols and selenium 
protect cells against UV radiation with a synergistic interaction through an increase in 
glutathione peroxidase (CPX) activity (Beani, 2001). 
 Zinc supplementatioalso has anti-carcinogenic activity in human colon cells exposed to 
the well–known carcinogen, cadmium (Cd). In this situation, a DNA repair activity known to 
play an important role in colon cancer can be reversed by zinc supplement, which acts on the 
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DNA mismatch repair (MMR) (Lutzen et al., 2004). This property of zinc has been explained by 
the inhibition of mismatch DNA repair of small misalignments and base-base mismatches 
(Beyersmann and Hechtenberg, 1997; Hartwig and Schwerdtle, 2002; McMurray and Tainer, 
2003; Lutzen et al., 2004). The zinc finger protein ZEC, which is strongly expressed in the testis, 
is involved in DNA damage recognition during nucleotide-excision repair (Chen et al., 1995; 
Asmuss et al., 2000). Hartwig and Kopera demonstrated that this inhibition of xeroderma 
pigmentosum, complementation group A (XPA) is due to a substitution of protein-bound zinc 
with cadmium (Hartwig and Schwerdtle, 2002; Kopera et al., 2004; Stewart, 2005). 
All the previously mentioned studies demonstrated that zinc directly or indirectly plays a 
vital role in the DNA repair system. 
1.3 Zinc Effects on Apoptosis 
A recent study showed that zinc, by down-regulating p53 activity, through inhibition of 
the ERK1/2 downstream signaling pathways promoted apoptosis in epithelial breast cancer cells 
by depolarizing the mitochondrial membrane. (Ostrakhovitch and Cherian, 2005). 
After exposure to isomeric Zn(II) N-methylpyridylporphyrins (ZnTM-2(3,4)-PyP4 +), 
colon adenocarcinoma cells showed morphological changes consistent with both necrotic and 
apoptotic death sequences, depending on the presence of oxygen (Al-Mutairi et al., 2007). 
. Zinc has been shown to induce apoptosis in several animal cells. For example, in a study 
of rat hippocampal neurons, the protective effect of growth inhibitory factor (GIF) against zinc-
induced neuronal death was demonstrated.(Liu et al., 2004) 
In a similar study using PC12 cells, intracellular accumulation of Zn, induced by the 
synergy of zinc and pyrithione, leads to an increase in apoptosis (Seo et al., 2001).. However, 
exposure to zinc does not always increase apoptosis. In a different study, zinc appears to have 
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anti-apoptitic activity on SH-SY5Y neuroblastoma cells by an ERK1/2 signal that reduces the 
mitochondria membrane potential effects (An et al., 2005). 
In 2005, Zago et al. showed that, in zinc-deprived conditions using IMR-32 cells in a 
model for neuronal cells, there are two ways in which zinc acts. First, zinc acting on ERK1/2 and 
p38, induces apoptosis by increasing the  N-terminal kinase (JNK). This is due to zinc 
deprivation. In other words, zinc negatively regulates JNK . Secondly; the supplementation of 
zinc has no effect on apoptosis. From these studies, zinc can induce apoptosis. Since Erk 
inhibition leads to release of the apoptosis-induced factor (AIF), the inhibition of ERK can lead 
to apoptosis via nuclear relocation after depolarizing of the mitochondrial membrane. This will 
inhibit the p53 expression and decrease cell life.  
1.4 Zinc Effects on Redox Homeostasis 
Recent studies of a colon-derived cell line showed that increasing intracellular zinc 
concentration has a protective effect on colon mucosa. In another study, Martelli and Moulis 
(2004) demonstrated that increases of both zinc and cadmium act on the thiol group and iron 
regulatory proteins (IRP). This will increase the level of iron and, subsequently, improve the 
function of erythrocytes through what is known as repairing of ion homeostasis (Blazovics et al., 
2004). 
Hao and Maret (2005), demonstrated that maintaining zinc homeostasis is critical in 
neurological disease where the zinc and zinc donor/acceptor pair (metallothionein/thionein), 
respectively, play the major role in maintaining the zinc homeostasis, based on the fact that zinc 
has no inert redox activity.  
From these findings, zinc supplementation,alone has no direct effect on  distribution, and 
redistribution play a critical role in redox homeostasis. 
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1.5 Reactive Oxygen Species (ROS), Oxidative Stress, and Disease  
Zinc enters the body primarily through ingestion and is stored in soft tissues, especially in 
the liver and kidneys. Among stress response genes are those encoding metallothionein (MT), 
heat shock proteins (HSP), proteins involved in oxidative stress, and glutathione (GSH) and 
related proteins (Stewart, 2005). Induction of these stress response genes is considered a cell-
protective mechanism (Ho and Ames, 2002; Stewart, 2005). 
Zinc, typical of other stress-related agents, stimulates transcription factors that interact 
with binding domains in the StRE. In addition, zinc acts on the signal transduction pathways by 
activating cellular protein kinases, which “results in increased phosphorylation of transcription 
factors leading to the activation of target genes” (Stewart, 2005). Therefore, zinc stimulates the 
transcription factor activity. 
ROS generation (either endogenous or exogenous) results of normal cellular respiration, 
inflammation, infection, tissue damage, and in response to stress-promoting stimuli, such as 
cadmium  (Ambrosone, 2000; Cadenas and Davies, 2000; Salvemini and Cuzzocrea, 2002; 
Stewart, 2005). Radical derivatives of molecular oxygen can interact with metals to form ROS 
(Halliwell et al., 2000; Nordberg and Arner, 2001). ROS, such as superoxide (O2-), hydrogen 
peroxide (H2O2), and hydroxyl radicals (OH●), are generated and degraded by all aerobic 
organisms (Figure 1.1) (Fang et al., 2002; Mates, 2000). In his dissertation, Stewart (2005) 
states: 
An increase in ROS formation leads to disruption of cellular homeostasis because of 
damage to cell components: i.e., protein modification, lipid peroxidation, membrane 
disruption, and DNA damage (including DNA strand breakage, DNA base modification, 
and DNA-protein cross-linkage) (Dean et al., 1997; Nordberg and Arner, 2001; Olinski et 
al., 2002; Marnett et al., 2003). In an environment with sufficient antioxidants, cells 
detoxify ROS and repair the cellular damage However, a continuing imbalance between 
ROS production and detoxification results in cellular oxidative stress (Mates, 2000; Davis 
et al., 2001) (Figure 1.2). Many human pathological conditions such as Alzheimer’s 
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disease, ischemia/reperfusion injury, diabetes mellitus, atherosclerosis, hypertension, 
acute-respiratory distress syndrome, and cancer have been associated with oxidative 
stress (Nordberg and Arner, 2001; Cho et al., 2002; Olinski et al., 2002). (p. 2) 
 
 
1.6 Oxidative Stress – The Cellular Response 
 
In  study by Alam et al ,demonstrated ,  \ that zinc has direct effects on changes multiple 
cellular processes that although largely secondary to the perturbation of redox homeostasis, 
result in ROS production and cellular oxidative stress (Martindale and Holbrook, 2002; Stewart, 
2005). Stewart (2005) also stated: 
To maintain cellular homeostasis and counter ROS damage, cells use both exogenous and 
endogenous antioxidants to detoxify ROS and break the chain of free radical formation. 
Exogenous mechanisms include vitamins and plant-derived phenolic antioxidants. 
Endogenous mechanisms include the expression of a select set of genes that encode 
cytoprotective proteins (Wild et al., 1999; Fang et al., 2002). (p. 13) 
Superoxide, hydrogen peroxide, and other peroxides, including antioxidant molecules and 
enzymes that are direct scavengers, such as reduced GSH, glutathione peroxidase (CPX), Cat, 
MT, and SOD (Figure 1.2) are effective defenses against ROS damage . (Dharkshinamoorthy 
and Jaiswal, 2000; Dharkshinamoorthy et al., 2000; Mates et al., 2000; Nordberg and Arner, 
2001; Stewart, 2005). A continuous ROS imbalance results in toxic amounts of ROS and 
oxidative stress, requiring detoxification or removal of toxins by induced antioxidant enzymes, 
e.g., NAD(P)H:quinine oxidoreductase (NQO1), -glutamylcysteine synthetase (y-GCS), 
thioredoxin (TRX), and glutathione S-transferase (GST) (Stewart, 2005). These antioxidant 
enzymes metabolize ROS and toxic compounds into forms that are readily excreted by the cell 
(Figure 1.2) (Itoh et al., 1997; Moinova and Mulcahy, 1999; Wild et al., 1999; Mates, 2000; Kim 
et al., 2003). 
Recent studies have identified heme oxygenase-1 (HO-1) as another inducible enzyme 










Figure 1.1  Generation of ROS. the products of heme–catalyzed reactions.  The peroxyl and 
alkoxyl radicals species may account for the peroxyl radical generation during decomposition 

















Figure 1.2 Detoxification of ROS by Antioxidant Enzymes.  ROS are generated during cellular 
aerobic metabolism and/or when cells are exposed to various stress conditions ( UV light, 
gamma radiation, environmental pollutants such as metals and xenobiotics, inflammatory 
cytokines, enzymatic disorders). ROS are radicals  like superoxide anion and the hydroxyl and 
peroxyl radicals, and also include hypochlorite ion (OCl-) and hydrogen peroxide (H2O2 ). They 
play important roles both in homeostatic mechanisms and pathogenic processes (IMAGE FROM 
www.meduniwien.ac.at/.inner-med-1/krebsforschung/science/staff/academy/../imgs/elbling-
fig1.gif) 
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1.7 Heme Oxygenase-1 and Cellular Homeostasis 
 
From the discovery of the HO-1 protein in the 1960s until recently, it was thought that 
the essential biological function of HO-1 was heme metabolism (Choi and Alam, 1996; Stewart, 
2005). Heme, a compound containing iron, facilitates vital cellular functions by functioning as 
the prosthetic group of proteins such as, hemoglobin, myoglobin, oxydemoglobin, cytochromes, 
catalase, guanylate cyclase, and nitric oxide synthase (Maines, 1988; Schwartsburd, 2001; 
Stewart, 2005). Hemoproteins deliver oxygen and enable mitochondrial respiration and signal 
transduction (Maines, 1988; Nath et al., 1996; Schwartsburd, 2001; Stewart, 2005). When cells 
are destroyed or damaged, lipophilic heme is released from its linkage with such proteins. Free 
heme ─with its reactive iron ─ acts as a pro-oxidant and generates ROS, causing DNA damage, 
protein denaturation, and lipid peroxidation (Vincent, 1989; Balla et al., 1991; Nath et al., 1996; 
Stewart, 2005). HO-1 regulates intracellular concentrations of heme in major tissues via the 
turnover of heme-binding proteins. Therefore, the highest concentrations of HO-1 are found in 
the spleen, liver, and kidneys, performing the critical function of hemoglobin-heme degradation 
during the turnover of erythrocytes (Maines, 1988; Choi and Alam 1996; Poss and Tonegawa, 
1997a, 1997b; Stewart, 2005). 
As Stewart (2005) wrote: 
 HO-1 enzymes catalyze the initial and rate-limiting step in the oxidative cleavage of b-
type heme molecules to yield equimolar quantities of iron, carbon monoxide, and 
biliverdin IXa, which is then metabolized further to bilirubin by biliverdin reductase 
(Figure 1.3) (Choi and Alam, 1996; Elbirt and Bonkovsky, 1999; Montellano, 2000; 
Otterbein and Choi, 2000). Two enzymatically active isoforms of HO, HO-1 and HO-2, 
encoded by distinct genes, have been identified and localized to the endoplasmic 


















Figure 1.3  Heme Degradation Pathway. Heme Oxygenase-1 (HO-1) degrades heme into iron, 
biliverdin (BVR), and carbon monoxide (CO). Biliverdin reductase (BVR) converts biliverdin 
into bilirubin. 
 
 Recent studies have convincingly shown that HO-1 is also a cytoprotective enzyme that 
acts as both an antioxidant and an anti-inflammatory, and also has a role in cell signaling and 
cellular homeostasis in response to injury and oxidative stress (Choi and Alam, 1996; Alam and 
Cook, 2003; Stewart, 2005). Stewart (2005) deduced these roles as a result of several 
observations about the HO-1 inducers and the by-products of heme degradation:  
1) In addition to the substrate heme, HO-1 expression is induced by a variety of stress 
conditions and agents including ultraviolet irradiation (UV), hyperthermia, 
lipopolysaccharides (LPS), inflammatory cytokines, heavy metals, hydrogen peroxide, 
hypoxia, hyperoxia, endotoxins, oxidized low-density lipoproteins, and cell and tissue 
injury (Choi and Alam, 1996; Maines, 1997; Montellano, 2000; Otterbein and Choi, 
2000; Alam and Cook, 2003). 
2) These and other stimuli generate cellular oxidative stress by producing ROS and/or 
modifying GSH levels (Abraham et al., 1995; Choi and Alam, 1996).  
3) Heme degradation by HO-1 eliminates a pro-oxidant heme and simultaneously 
generates products that are antioxidants, biliverdin and bilirubin (Stocker, 2004).  
4) The release of heme-iron, which acts as an effective catalyst in the generation of ROS, 
induces the synthesis of the iron-sequestering protein ferritin and reduces the level of 
transferring receptor (TfR), which is involved in the uptake of iron (Ward et al., 1984; 
Choi and Alam, 1996; Arosio and Levi, 2002). 
5) CO, a diffusible gas, functions as a neural messenger and has vasodilatory, 
antiproliferative, and anti-inflammatory properties (Choi and Alam, 1996; Maines, 1997; 
Otterbein and Choi, 2000). Thus, HO-1 activation appears to be a general response 
against oxidative stress in cells and tissues caused by various stressful stimuli and 













HO-1 functions as an anti-oxidative, an anti-inflammatory, and a cytoprotective enzyme, 
as observed in multiple studies utilizing both animal and cell culture models of injury or disease 
(Choi and Alam, 1996; Stewart, 2005). For instance, Nath et al. (1996) showed that, in rats, 
release of heme from myoglobin using glycerol resulted in kidney failure and death; whereas 
induction of HO-1 by preinfusion of hemoglobin avoided kidney failure and a reduced mortality 
(Nath et al., 1998; Stewart, 2005). In yet another experiment, rats pretreated with hemoglobin 
had increased survival after a lethal injection of LPS, which coincided with increased HO-1 
expression (Otterbein et al., 1995; Stewart, 2005). Stewart (2005) also stated: 
Induction of HO-1 by a sublethal dose of UVA protects human skin fibroblasts 
against a subsequent lethal dose of UVA, whereas administration of anti-sense 
oligonucleotides directed against HO-1 transcripts attenuated the cytoprotective response 
(Vile et al., 1994). In an in vitro cell study, ectopic expression of HO-1 in cultured 
endothelial cells provided protection against heme and hemoglobin toxicity (Abraham et 
al., 1995). Furthermore, neurons over-expressing HO-1 resisted oxidative stress-induced 
cell death, and over-expression of HO-1 inhibits tumor necrosis factor-alpha (TNF-α) 
induced apoptosis (Stocker et al., 1990; Goodman et al., 1997; Poss and Tonegawa, 
1997a, 1997b; Petache et al., 2000). (p. 19) 
Although the protective function of HO-1 has been documented in the oxidative stress-
mediated injury of cellular and animal models, the biological importance of HO-1 is most 
evident in the physiological abnormalities (i.e., growth retardation, anemia, leukocytosis, and 
tissue iron deposition) observed in mice and a single human with HO-1 deficiency (Choi and 
Alam, 1996; Poss and Tonegawa, 1997a, 1997b; Kawashima et al., 2002; Stewart, 2005). Also, 
mating between heterozygous HO-1 mice results in partial prenatal lethality of the HO-1 
deficient mice; homozygous mating pairs do not yield viable litters (Stewart, 2005). 
Furthermore, when endotoxin was administered to HO-1 deficient mice, the result was an 
increase in liver injury and mortality; (Montellano, 2000). Likewise, HO-1 deficient embryo 
fibroblasts cells were hypersensitive to heme, H2O2, cadmium, and hydrogen peroxide treatment 
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and exhibited increased intracellular ROS production, which indicates that HO-1 expression is 
important in the defense against oxidative stress(Choi and Alam, 1996; Maines, 1997). 
1.8 Regulation of the hmox-1 Gene 
As previously stated, in addition to heme and the various extracellular agents listed 
above, HO-1 expression is also upregulated under certain physiological conditions, such as 
exercise and pregnancy, or the pathophysiological conditions associated with increased ROS 
production (inflammation, sepsis, ischemia-reperfusion injury, atherosclerosis, diabetes mellitus, 
AIDS, and Parkinson’s and Alzheimer’s diseases) (Choi and Alam, 1996; Pilegaard, 2000; Cosso 
et al., 2001; McLaughlin et al., 2003; Stewart, 2005). Although not all agents or conditions have 
been tested, accumulating data supports the idea that HO-1 induction by most, if not all, stimuli 
is regulated at the level of gene transcription (Choi and Alam, 1996; Alam and Cook, 2003; 
Stewart, 2005). 
The work in our lab on hmox-1 gene has been most extensively done on the mouse. The 
coding portion of the mouse hmox-1 gene is approximately 7 kilobase pairs (kbp) in length. It is 
organized into 5 exons and 4 introns (Figure 1.4) (Alam et al., 1994; Stewart, 2005). Functional 
analyses of the mouse hmox-1 promoter enabled the identification of two 5’ distal enhancers, E1 
and E2, located approximately -4 and -10 kbp, respectively, upstream from the transcription start 
site (Figure 1.4) (Stewart, 2005). These distal enhancers exhibited both basal level and inducer-
dependent transcriptional activities (Alam and Zhining, 1992; Alam et al., 1994; Alam et al., 















Figure 1.4  Enhancer elements (E1, E2) localization within the hmox-1 Gene. Proximal Promoter 
(PP) cis-elements localized within the hmox-1 gene PP and enhancer regions (E1 and E2). Exons 
are designated by rectangles; open segments indicate 5’ and 3’ untranslated regions. +1, 
transcription start site. Numbers are in base pairs. 
 The mapping of the E1 and E2 enhancers identified a dominant cis-acting element, called 
the stress response element (StRE), present in multiple copies within each enhancer (Stewart, 
2005). The StRE’s importance resulted from its role in hmox-1 induction in response to most 
agents tested, including CdCl2, HgCl2, 12-O-tetra-decanoylphorbol- 13-acetate (TPA), 
hyperoxia, heme, LPS, and H2O2 (Choi and Alam, 1996; Alam and Cook, 2003; Stewart, 2005). 
The sequence, location, and number of the StREs between the mouse, rat, and human hmox-1 
genes were conserved, further pointing to the importance of these elements (Alam and Cook, 
003; Alam et al., 2004: Stewart, 2005). 
Stewart (2005) wrote: 
Sequence comparison and mutation analyses have identified the minimal consensus StRE 
as the 10-bp sequence (T/C)GCTGAGTCA (Prestera et al., 1995; Choi and Alam, 1996; 
Inamdar et al., 1996). The consensus closely resembles the consensus binding site for 
various families of transcription factors, including AP-1, CREB/ATF, Maf, 
Cap’N’Collar-basic-leucine zipper (CNC-bZIP), and Bach families of transcription 
factors, all of which belong to the bZIP class of sequence-specific DNA-binding proteins 
(Table 1.1). This similarity suggested that one or more members of these families of 
proteins may function as StRE-binding proteins and inducer-dependent hmox-1 
activators. (p. 20) 
1.9 Nrf-2 Regulation of the hmox-1 Gene  
During a previous study in our lab using various experimental strategies, Nrf-2 (NF-E2 
related factor 2) ─ a member of the CNC-bZIP family ─ was identified as the dominant regulator 
E2 E1
-15kb -12 -9 -3-6
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of hmox-1 gene activation in response to multiple inducers (Stewart, 2005). Those inducers 
included heme, cadmium, cobalt, curcumin, 15-deoxy-∆12,14 – prostaglandin J2 (15d-PGJ2), 
and arsenite in multiple cell types, including fibroblast, hepatoma, human mammary epithelial, 
and Chinese hamster ovary (CHO) cells (Alam et al., 1999; Alam et al., 2000; Gong et al., 2001; 
He et al., 2001; Gong et al., 2002a, 2002b; Balogun et al., 2003: Stewart, 2005).  
Many of the agents listed above increased the StRE-binding activity of Nrf-2, as studied 
by electrophoretic mobility shift assays (EMSA) (Stewart, 2005). Also, transfection of fibroblast 
cells with candidate transcription factors showed that members of only the CNC/bZIP family of 
proteins effectively activated an E1 luciferase reporter construct; Nrf2- displayed the strongest 
activity (Alam et al., 1999; Stewart, 2005).  
Stewart (2005) wrote: 
Conversely, overexpression of the dominant negative mutant (DNM) form of Nrf2 
inhibits E1 activity and endogenous HO-1 mRNA expression in the above cell types in 
response to various inducing agents, including cadmium, 15d-PGJ2, heme, arsenite, and 
cobalt (Alam et al., 1999; Alam et al., 2000; Gong et al., 2001; He et al., 2001; Gong et 
al., 2002a, 2002b). Additional studies (Ishii et al., 2000) demonstrated that macrophages 
derived from Nrf-2-deficient mice exhibit reduced hmox-1 gene activation by several 
stimuli, including cadmium. In contrast, overexpression of Nrf-2 in several cell lines 
increased the expression of cytoprotective genes, including hmox-1 (Alam et al., 1999; 
Kim et al., 2003; Shih et al., 2003). These observations suggest that Nrf-2 is an essential 
regulator of hmox-1 gene activation during the adaptive response to oxidative stress. (pp. 
24-25) 
1.10 Structural Characteristics of Nrf-2 (NF-E2):  
in head and neck development in drosophila (Mohler et al., 1991). Stewart (2005) also     stated 
that 
The transcription factors that regulate activation of stress-responsive genes encoding proteins with antioxid 
oxidative stress. Our laboratory studies have identified Nrf-2 as a key stress-responsive transcription factor (Alam et 
al., 1999; Stewart, 2005). Nrf-2, similar to other members of the CNC-bZIP family, contains a Cap’N’Collar (CNC) 
domain “homologous to a region within the fruit fly homeotic selector protein encoded by the CNC gene” (Stewart, 
2005), which is involved ant and cytoprotective activities are central to the response to cellular 
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StRE TGCTGA GTCAC  Choi and Alam, 1996 
 
NF-E2 binding site TGCTGA GTCACCCT CNC-bZIP/Maf 
heterodimers 
Andrews, 1998 















TGA GTCA                     
C 
AP-1 (Fos/Jun) Karin et al., 1997 
CRE:cAMP 
  response element 
TGACGTCA                    CREB/ATF Hai et al., 1999 
 
                                                 
1  Stewart, D. (2005). Mechanism of Hmox-1 induction by cadmium. Unpublished doctoral dissertation, 
Louisiana State University, New Orleans. (p. 24) 
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Nrf2 also contains a potent N-terminal transcription activation domain (TAD), a nuclear 
localization signal (NLS), a nuclear export signal (NES), and two conserved structural 
motifs, the C-terminal leucine dimerization (LZ) and basic DNA-binding domains (DBD) 
(Figure 2.1) (Alam et al., 1999; Alam et al., 2004; Shen et al., 2004; Jain et al., 2005). 
The dimerization domain consists of a heptads repeat with leucine residues every seventh 
position, the leucine zipper that is necessary for polypeptide dimerization, and an 
adjacent DNA-binding domain enriched in basic amino acids (Kouzarides and Ziff, 1988; 
Struhl, 1989). (p. 28) 
The chief structure within the leucine zipper region of Nrf-2 prevents self-dimerization. 
Therefore, Nrf-2 heterodimerizes predominantly with: small, Maf proteins (MafF, MafG, 
andMafK); other bZIP proteins, including c-Jun of the AP-1 family; and ATF-4 (activator of 
transcription 4) (Venugopal and Jaiswal, 1998; Nguyen et al., 2000; He et al., 2001, Alam and 
Cook, 2003), a member of the ATF/CREB subfamily (Venugopal, 2001; Stewart, 2005). 
1.11 Physiological Significance of Nrf-2 
New data indicate that Nrf-2 acts as a primary regulator of the adaptive response to 
oxidative stress (Alam and Cook, 2003; Alam et al., 2004; Stewart, 2005). Recent studies show 
that Nrf-2 regulates the inducible expression of genes encoding enzymes with cytoprotective 
functions such as NQO1, GST, TRX, y-GCS, ferritin H, and HO-1 (Venugopal and Jaiswel, 
1998; Wild et al., 1999; Jeyapaul and Jaiswal, 2000; Dhakshinamoorthy et al., 2000a, 2000b; 
Pietsch et al., 2003; Alam and Cook, 2003; Stewart, 2005). These enzymes work together as a 
cellular defense apparatus that “scavenges ROS, detoxifies electrophiles, and xenobiotics,” 
(Stewart, 2005) and maintains intracellular redox homeostasis (Thimmulappa et al., 2002; Lee et 
al, 2003; Shih et al., 2003). 
Nrf-2-deficient mice develop normally, but are extremely sensitive to butylated 
hydroxytoluene, develop acute-respiratory distress syndrome: are prone to acetaminophen 
hepatotoxicity; and present an increased burden on benzo[a] pyrene-induced gastric neoplasia 
(Chan et al., 2001; Enomoto et al., 2001; Ramos-Gomez et al., 2001; Stewart, 2005). 
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In addition, Stewart (2005) stated that: 
. . . macrophages derived from such mice “exhibit reduced resistance to toxic 
electrophiles (Ishii et al., 2000). Consistent with this idea, deletion of the Nrf-2 gene in 
mice shows a substantial decrease in antioxidant gene expression accompanied by an 
increased susceptibility to carcinogenesis (Ishii et al., 2000; Ramos-Gomez et al., 2001; 
Enomoto et al., 2001; Lee at al., 2003). These studies indicate that Nrf-2 provides an 
important mechanistic link between oxidative stress and antioxidant gene expression in 
supporting cell survival and cellular homeostasis. (p.31) 
1.12 Nrf-2 Activity Regulation  
There is quite a bit known about the regulation of Nrf-2 target genes, such as hmox-1, but 
the “mechanisms by which stress agents regulate Nrf2 activity are not well characterized’” 
(Stewart, 2005). Laboratory evidence indicates that Nrf2 activity is, at least partially, regulated at 
the level of subcellular compartmentalization (Itoh et al., 1999; Dinkova-Kostova et al., 2002; 
Sekhar et al., 2002; Zipper and Mulcahy, 2002; Stewart, 2005). Nrf-2 exists normally in an 
inactive form in the cytoplasm by binding to a  protein, Keap1 (Kelch-like ECH-associated 
protein 1) (Itoh et al., 1999; Dhakshinamoorthy and Jaiswal, 2001; Kobayashi et al., 2002; 
Sekhar et al., 2002)..  
After Nrf-2 has been stimulated by oxidative stress promoting agents, it is liberated from 
Keap 1 suppression. This allows Nrf-2 to transfer to the nucleus where it activates target genes, 
by a currently uncharacterized mechanism, but one that perhaps involves PKC-mediated 
phosphorylation of Nrf-2 (Huang et al., 2002; Stewart, 2005). This mechanism is similar to the 
cytoplasmic-nuclear transport mechanism of transcription factors NF-κB and p53 (Crook et al., 
1998; Kau and Silver, 2003; Stewart, 2005).  
Another mechanism of regulation may occur at the level of DNA binding. The 
association and DNA-binding of Nrf-2 Jun dimers requires a cytosolic factor, which has, to date, 
remained uncharacterized (Venugopal and Jaiswal, 1998; Jaiswal, 2000; Jeyapaul and Jaiswal, 
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2000; Stewart, 2005). Whether this factor is responsive to oxidative stress and how it regulates 
nuclear activity remain to be seen (Stewart, 2005). Stewart (2005) also stated that: 
Recent studies by Kwak et al. (2002) have described a positive feedback mechanism in 
which Nrf-2 autoregulates its own expression via an antioxidant response element-like 
sequence within the Nrf2 gene in response to 3H-1,2 –dithiole-3-thione, an anti-
carcinogen. (p. 32) 
The goal of this research is to investigate the subcellular characteristics and cytoplasmic-
nuclear transport of Nrf-2 in Hepa cells. It will be observed if various HO-1 inducers actually 
increase the steady-state level of Nrf-2. In the present study, an alternative mechanism of Nrf-2 
regulation is described.  
1.13 Summary and Rationale for Studies 
In summary, ROS produced during cellular metabolic activity, or in response to 
exogenous agents, are detrimental to cellular structures as they damage lipids, proteins, and 
DNA. Two environmental pollutants, the cadmium and zinc, are toxic and carcinogenic. Zinc 
alters multiple cellular processes, and the generation of ROS and oxidative stress. Disruption of 
cellular activities by excessive ROS leads to an adaptive response involving the coordinate 
induction of a select set of genes that encode proteins with antioxidant and cytoprotecitve 
functions. HO-1 has been identified as an important inducible enzyme with antioxidant and 
cytoprotective activities that function against oxidative stress in response to various stress 
stimuli.  
The cytoprotective function of HO-1 is dependent not only on the activities of the 
reaction products but on the induciblity of HO-1, which is regulated primarily at the level of 
gene transcription by two distal enhancers E1 and E2. Identification and analysis of the 
enhancers led to the discovery of multiple StREs that are necessary and sufficient for hmox-1 
gene regulation by almost all inducers. Additionally, studies from our laboratory identified Nrf-
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2, a CNC-bZIP transcription factor, as a dominant regulator that mediates inducer-dependent 
regulation of the hmox-1 gene via the StRE motifs by several inducers, However, the mechanism 
of how Nrf-2 is regulated is in terms of zinc is not completely understood. I will study the role of 
the Nrf-2 in the HO-1 induction by zinc .. 
In the following chapters, supporting experiments will be discussed where zinc induces 
the hmox-1 gene promoter in a dose-dependent manner by different approaches, such as 
luciferase assay, mRNA blotting, and electrophilic mobility shift assay (EMSA). 
It will be shown that the increase in the hmox-1 induction has a profound positive impact 
on the increase of the StREs, which have multiple copies in the E1 region of hmox-1. It will be 
demonstrating that there is strong Nrf-2 binding and that this binding is a perquisite for HO-1 
expression. 
Furthermore, in Chapter Three, it will be shown which signal transductions are activated 
by supplementation of zinc and which one is responsible for HO-1 upregulation. A model will be 
described that links Nrf-2 and ERK1 in the mechanism by which zinc increases the HO-1 
expression. 
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2. INDUCTION OF THE HEME OXYGENASE-1(hmox-1) GENE IN RESPONSE TO 
ZINC IS MEDIATED BY THE STRESS RESPONSE ELEMENTS (StREs) AND 
NUCLEAR FACTOR-ERYTHROID 2 RELATED FACTOR-2 (Nrf-2) 
 
2.1 Introduction 
The liver is the primary organ of zinc metabolism, which can lead to liver damage 
(Bailey and Cunningham, 2002).,Contribution of mitochondria to oxidative stress associated 
with liver disease. Oxidative stress, and more precisely, the generation of excessive ROS (such 
as hydroxyl ethyl free radicals, hydroxyl radicals, and superoxide anions), inducing cellular 
damage by targeting various molecules, such as proteins, lipids, and DNA. It has been suggested 
that ROS are produced during zinc metabolism through different metabolic pathways. For 
example, Palmiter et al. (2004) demonstrated that phenolic oxidants activate Mt1 transcription by 
a zinc-dependent mechanism, which involves MTF-1 binding to metal regulator elements in the 
Mt1 gene promoter.(Bi et al., 2004). In another pathway, Cui et al. (2003) demonstrated that 
certain transcription factors are involved in the regulation of apolipoprotein A-I (apoAI) 
expression in human hepatoblastoma Hep G2 cells. Ho (2003) demonstrated that 
supplementation of zinc to C6 cells increases oxidative DNA damage and induce DNA-repair 
protein expression. Important downstream signals leading to proper DNA repair are lost without 
zinc. 
At the cellular level, what happens to zinc after it gets to the nucleus of the cells?  
Regardless of the of the kind of MAPK signal(s), it is generally well known that the main 
function of all kinds of MAPKs is to tightly control the activity of transcription factors in order 
to regulate the expression of a large number of specific genes (Murphy et al., 2006). 
In study by Alam et 2003 demonstrated that the hmox-1 gene is activated in response to 
heavy metals treatment (including cadmium and 15-deoxy-∆ 12, 14 –prostaglandin J2) in several 
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cell types, including Hepa cells, by the transcription factor Nrf-2 via StREs in the E1 enhancer 
(Alam et al., 2000; He et al., 2001; Stewart et al., 2003). However, the mechanism by which zinc 
induces HO-1 was not studied in detail. Stewart et al. (2003) wrote: 
In these studies, additional work demonstrated that two 5’ distal enhancer regions 
mediate mouse hmox-1 gene activation in response to multiple inducers including heme, 
cadmium, and 15-deoxy-∆ 12, 14 –prostaglandin J2 (Alam et al., 2000, Gong et al., 2002a, 
2002b; Balogun et al., 2003). Additionally, from our previous lab work, ectopic 
expression of an Nrf-2 dominant negative mutant (DNM) did not completely inhibit 
activation of the hmox-1 gene or the E1-controlled luciferase gene by cadmium in several 
cell types, including Hepa cells (Alam et al., 1999; Alam et al., 2000; He et al., 2001). 
Furthermore, Ishii et al. (2000) have observed that Nrf-2-deficient macrophages are still 
capable of partial induction of HO-1 protein and mRNA expression when treated with 
cadmium, suggesting that other transcription factors and cis-acting DNA elements may 
be involved in hmox-1 gene regulation.  (p. 23) 
One potential element, the StRE, was identified in the mouse hmox-1 gene by Takeda et 
al. (1994) in Hepa cells. This (StRE) resides in the mouse hmox-1 E1 locus. Conversely, the 
StREs within the E1 loci of the human , rat, and mouse genes were conserved with respect to 
number, relative location, and primary structure (Alam et al., 2000; He et al., 2001; Stewart et 
al., 2003). Specifically, the E1 sequence of the mouse, rat, and human hmox-1 genes exhibited 
55% overall sequence conservation (Alam and Cook, 2003; Stewart et al., 2003). This level of 
sequence identity suggests that other elements within E1 may contribute to gene activation. In 
this chapter, evidence will be provided that StREs and/or HSEs are necessary for this regulation. 
It will also be shown that StREs have multiple motifs in the E1 region when they bind to 
transcription factor Nrf-2, which activates the mouse hmox-1 gene in response to zinc (Stewart, 
2003).  
2.2 Nrf-2 Structural Characteristics  
Previous studies by Alam et al. (1999) showed that Nrf-2 is an important transcription 
factor with a primary role in the response to cellular oxidative stress. Transcription factors 
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regulate activation of stress responsive genes, encoding proteins with antioxidant and 
cytoprotective activities. Nrf-2 is a member of the CNC-bZIP family. This family contains a 
Cap’N’Collar (CNC) domain similar in structure to a region within the fruit fly homeotic selector 
protein encoded by the CNC gene involved in head and neck development in Drosophila. This is 
common among the CNC-bZIP family (Mohler et al., 1991). Nrf-2 also contains many domains; 
for example, a potent N-terminal transcription activation domain (TAD); a nuclear localization 
signal (NLS); a nuclear export signal (NES); and two conserved structural motifs, the C-terminal 
leucine dimerization (LZ) and basic DNA-binding domains (DBD) (Figure 2.1) (Alam et al., 
1999; Alam et al., 2004; Shen et al., 2004; Jain et al., 2005; Stewart, 2005).  
Stewart (2005) wrote: 
The dimerization domain consists of repetitions of leucine residues every seventh 
position; the leucine zipper, which plays an important role in polypeptide dimerization; 
and an adjacent DNA-binding domain enriched in basic amino acids (Kouzarides and 
Ziff, 1988; Struhl, 1989). The primary structure within the leucine zipper region of Nrf-2 
precludes self-dimerization; therefore, Nrf2 heterodimerizes primarily with small Maf 
proteins (MafF, MafG, and MafK), and other bZIP proteins including c-Jun of the AP-1 
family and ATF-4 (activator of transcription 4), a member of the ATF/CREB subfamily 
(Venugopal and Jaiswal, 1998; Nguyen et al., 2000; He et al., 2001, Alam and Cook, 
2003). Other mammalian CNC family members include p45, Nrf-1 (NF-E2 related 
factors), Nrf-3, Bach1, and Bach2 (Chan et al., 1996; Oyake et al., 1996; Andrews, 
1998). (p. 28)   
 
 TAD CNC DBD LZ  
              
              
              
            NLS    NES 
 
Figure 2.1  A Presentation of Nrf-2 Domains. NF-E2(Nuclear factor-erythroid) domain Six 
highly-conserved regions, referred to as Neh1 to Neh6 (Nrf-2-ECH homology. N-terminal 
transcription activation domain (TAD); Cap’N’Collar (CNC), a nuclear localization signal 
(NLS), C-terminal leucine dimerization (LZ) and basic DNA-binding domains (DBD). 
 
NH2 - COOH 
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Studies by Alam et al. (1999) showed that Nrf-2 is an important transcription factor with 
a primary role in the response to cellular oxidative stress. Transcription factors regulate 
activation of stress responsive genes, encoding proteins with antioxidant and cytoprotective 
activities. Nrf-2 is a member of the CNC-bZIP family. This family contains a Cap’N’Collar 
(CNC) domain similar in structure to a region within the fruit fly homeotic selector protein 
encoded by the CNC gene involved in head and neck development in Drosophila. This is 
common among the CNC-bZIP family (Mohler et al., 1991). Nrf-2 also contains many domains; 
for example, a potent N-terminal transcription activation domain (TAD); a nuclear localization 
signal (NLS); and two conserved structural motifs, the C-terminal leucine dimerization (LZ) and 
basic DNA-binding domains (DBD) (Figure 2.1) (Alam et al., 1999; Alam et al., 2004; Shen et 
al., 2004; Jain et al., 2005; Stewart, 2005).  
2.3 Nrf-2 Physiological Importance  
The efficacy of Nrf-2 was discovered from the accumulating studies that implicated it as 
a key regulator of the adaptive response to oxidative stress (Alam and Cook, 2003; Alam et al., 
2004; Stewart, 2005). Additional studies in the past several years have convincingly 
demonstrated the regulation of the inducible expression of gene encoding enzymes with 
cytoprotective functions such as NQO1, GST, TRX, y-GCS, ferritin, and hmox-1 with Nrf-2 
(Venugopal and Jaiswal, 1998; Wild et al., 1999; Jeyapaul and Jaiswal, 2000; Dhakshinamoorthy 
et al., 2000a, 2000b; Alam and Cook, 2003; Pietsch et al., 2003). These enzymes work, in 
concert, as a cellular defense tool that scavenges ROS, detoxifies electrophiles and xenobiotics, 
and maintains intracellular redox-homeostasis (Thimmulappa et al., 2002; Lee et al., 2003; Shih 
et al., 2003). 
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Although, Nrf-2-deficient mice exhibit normal development, they are highly sensitive to 
butylated hydroxytoluene and suffer from acute respiratory distress syndrome, are susceptible to 
acetaminophen hepatotoxicity, and exhibit an increased burden of benzo[a]pyrene-induced 
gastric neoplasia (Chan et al., 2001; Enomoto et al., 2001; Ramos-Gomez et al., 2001).  
Furthermore, Ishii et al. (2000) demonstrated that macrophages derived from such mice 
exhibit reduced resistance to toxic electrophiles. Likewise, deletion of the Nrf-2 gene in mice 
results in a significant decrease in antioxidant gene expression with an increased susceptibility to 
carcinogenesis (Ishii et al., 2000; Enomoto et al., 2001; Ramos-Gomez et al., 2001; Lee et al., 
2003). These studies indicate that Nrf-2 performs an important role in bridging the gap between 
oxidative stress and antioxidant gene expression in supporting cell survival and cellular 
homeostasis. 
2.4 Nrf-2 Activity Regulation  
Although much is known about the regulation of Nrf-2 target genes, including hmox-1, 
the ways in which stress agents regulate Nrf-2 activity are not specifically characterized in terms 
of zinc. Evidence from several laboratories suggests that Nrf-2 activity is, in part, regulated at the 
subcellular compartmentalization level (Itoh et al., 1999;  Dinkova-Kostova et al., 2002; Sekhar 
et al., 2002; Zipper and Mulcahy, 2002;). Under normal conditions, Nrf-2 exists in an inactive 
form, sequestered in the cytoplasm in part ─ or fully ─ as a consequence of binding to a 
cytoskeleton-associated protein Keap1 (Kelch-like ECH-associated protein 1) (Itoh et al., 1999; 
Dhakshinamoorthy and Jaiswal, 2001; Kobayashi et al., 2002; Sekhar et al., 2002). After it is 
stimulated by oxidative stress promoting agents, Nrf-2 is freed from Keap1 suppression, which 
allows Nrf-2 to translocate to the nucleus and activate target genes by an, as yet, uncharacterized 
mechanism, but one by which it may be assumed that involvement of PKC-mediated 
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phosphorylation of Nrf-2 (Huang et al., 2002). This method of regulation is somewhat similar to 
the cytoplasmic-nuclear transport mechanism of transcription factors  
NF-κB and p53 (Crook et al., 1998; Kau and Silver, 2003).  
Another mode of regulation may be at the level of DNA binding. The association of 
motif-DNA-binding of Nrf-2-Jun dimmers has been shown to require a cytosolic factor yet to be 
characterized (Venugopal and Jaiswal, 1998; Jaiswal, 2000; Jeyapaul and Jaiswal, 2000). 
Whether such a factor is responsive to oxidative stress and how it regulates nuclear activity are 
not known. Studies by Kwak et al. (2002) have recently described a positive feedback 
mechanism in which Nrf-2 autoregulates its own expression via an antioxidant response 
element–like sequence, which shows sequence similarity to StRE, within the nrf-2 gene in 
response to 3H-1, 2-dithiole-3-thione, an anti-carcinogen. 
Since other studies have revealed that Nrf-2 plays important roles in HO-1 induction by 
heavy metals (Alam et al., 2003), this chapter will investigate how these transcription factors 
may be regulating this mechanism. Treatment of Hepa cells with increasing doses of ZnSO4 
caused greater expression of Nrf-2 . Since HO-1 production is primarily controlled by 
transcriptional regulation, it will be examined how Nrf-2 adjusts HO-1 expression in Hepa cells. 
By using EMSAs performed using oligo 5’-
ATCCCCGGAACAGGAGAAGGCCTTTTTCAAGAGAAAAGGCCTTCTCCTGTTCCTTTT
TGGAA -3’ and 5’-
AGCTTTTCCAAAAAGGAACAGGAGAAGGCCTTTTCTCTTGAAAAAGGCCTTCTCCTG
TTCCGGG-3, it will be demonstrated that direct binding of hmox-1 cis-regulatory elements by 
transcription factors shows Nrf-2) definitely contributing to the regulation of HO-1. 
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Experiments were performed to study the effects of treating the Hepa cells with heat shock, Cd, 
As, and zinc. Zinc caused the formation of DNA-protein complexes. I will also show the effect 
of zinc on the Hepa cells containing the reporter construct, pHO-15luc and wild-type Hepa cells 
(both treated with Nrf-2 ), and control shRNA. Then I will show that the basal and zinc-induced 
transcription after measuring luciferase assays in the cells containing pHO-15luc.  
2.5 Experimental Procedures 
2.5.1 Materials 
Tissue culture media and gentamicin were from Invitrogen (Carlsbad, CA), and fetal 
bovine serum was obtained from Atlanta Biologicals (Lawrenceville, GA). Restriction 
endonucleases and other DNA-modifying enzymes were purchased from either Invitrogen or 
New England Biolabs (Beverly, MA). Zinc sulfate was purchased from Sigma Inc. with 99.0% 
purity and kept at room temp.. Oligonucleotides were synthesized by IDT, Inc. (Coralville, IA) 
and radiochemicals were obtained from MP Biomedicals, Inc. (Irvine, CA). Antibodies against 
HSF-1, and β-Actin were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA), 
whereas antibodies against HSP70, HO-1, and HSF-1 were acquired from StressGen Biotech. 
Inc. (Victoria, Canada). Phosphatase inhibitors were purchased from Calbiochem (San Diego, 
CA) 
2.5.2 Plasmids 
Plasmid pHO-15luc was constructed by cloning a 15-kbp promoter fragment from the 
mouse hmox-1 gene (Alam et al., 1994) into the luciferase reporter gene vector pSKluc (Alam et 
al., 2000). Derivatives of pHO-151uc have been described previously (Gong et al., 2002a, 
2002b). A 3’ extension of hmox-1 enhancer 1 (E1), E1+ was generated by ligating the 268 bp E1 
fragment (Sac1 and Xbal ends) to a double-stranded oligonucleotide (prepared by annealing 5’-
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CTAGAAAGGCACAGAAGTTTCTTGTTTAATTTTA-3’ and  
5’-CTAGTAAAATTAAACAAGAAACTTCTGTGCCTTT-3’) with Xbal and Spel ends. The 
E1+ fragment was subsequently cloned between the Sac1 and Spel sites of p∆44luc, a luciferase 
reporter vector containing the hmox-1 core promoter from -44 to +73, including the TATA BOX, 
to generate pE1+-luc. Plasmid pE1+ (HSEmut)-luc a derivative of pE1+-luc with a mutant HSE, 
was created in a similar manner using the complementary oligonucleotides 5’-
CTAGAAAGGCACAGAAGTTTCTTGTTTAATTTTA-3’ and 5’-
CTAGTAAAATTAAACAAGAAACTTCTGTGCCTTT-3’ (mutant residues underlined).  
The StRE mutant and the StRE and HSE double mutant of E1+, pE1+ (StREmut)-luc and, 
respectively, were constructed in an analogous manner, except that the base E1 fragment was 
derived from pE1M789-luc in which the three StREs are mutated. 
Plasmid pSUPER/ Nrf-2 (192) expresses a small hairpin RNA (shRNA) targeting mouse 
Nrf-2 transcript and was constructed by cloning the complementary oligonucleotides, 5’-
ATCCCCGGAACAGGAGAAGGCCTTTTTCAAGAGAAAAGGCCTTCTCCTGTTCCTTTT
TGGAA -3’ and 5’-
AGCTTTTCCAAAAAGGAACAGGAGAAGGCCTTTTCTCTTGAAAAAGGCCTTCTCCTG
TTCCGGG-3’, into the pSUPER vector (Oligoengine). Plasmid pCMV/B-gal, encoding the E. 
coli B-galactosidase gene, was kindly provided by Dr. Ping Wei  (Louisiana State University 
Medical Center,New Orleans, LA). 
2.5.3 Cell Culture 
Normal mouse hepatoma (Hepa) cells, Hepa stable transfectants harboring pHO-151uc 
,or pSUPER/ Nrf-2 [192] ,and transformed mouse embryonic fibroblast (MEF) cells from wild-
type and HSF-1 knockout BALB/c mice were cultured in a humidified atmosphere (95% air, 5% 
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CO2) at 37°C in Dulbecco’s modified Eagle’s medium containing 0.45% glucose, 10% fetal 
bovine serum, and 50 μg/ml gentamicin. 
The media for MEF cells was additionally supplemented with 10 mM nonessential amino 
acids and 0.1 mM B-mercaptoethanol. Cells were routinely passaged every 3-4 days.  
2.5.4 Transfection, Treatment, and Reporter Enzyme Assays  
Transient transfection of Hepa cells were carried out using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s recommendations. Briefly, Hepa cells were seeded 
(~7 x 104/well of 24-well plate) and transfected 20 to 24 h later with a plasmid DNA mixture 
consisting of 0.1 μg of the experimental luciferase reporter construct and 0.1 μg of pCMV/B-gal.  
Between 20 to 24 h after the start of transfection, the culture medium was replaced with 
serum-free medium. The cells were cultured for another 24 h prior to treatment with chemical 
agents for 5 h in serum-free medium buffered with 10 mM Hepes (pH 7.3) at 37°C. Hepa/pHO-
151uc stable transfectants were cultured for 48 h prior to serum-starvation and treated as 
described above. Additional information is provided in the figure legends. 
2.5.5 Transfection and Reporter Enzyme Assays 
Briefly, for transient transfection, Hepa cells were seeded (~7 x 10 4/ well of 24-well 
plate; ~3 x 105  /35-mm plate) and transfected 20 to 24 h later with a plasmid DNA mixture 
consisting of 0.1 up of the experimental luciferase reporter constructs and 0.1 ug of pCMV/B-
gal, or for RNA inteference experiments, 50 ng p∆44luc/ME1+, 50 ng of pCMV/B-gal, and 100 
ng of the appropriate shRNA construct, subjected to heat shock (43°C) for 0.5 h in complete 
media, followed by a 5.5-h recovery period at 37°C.  
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2.5.6 RNA Isolation and Blot Analyses  
Hepa cells were seeded (1 x 106 cells/60-mm plate); cultured for 40 to 48 h, first in 
complete medium and then, for an additional 24 h in serum-free medium; and then treated with 
the appropriate agents for 3 h in serum-free medium buffered with 10 mM Hepes (pH 7.0-7.6) 
(Sigma). Total RNA was isolated by the acid-guanidine-thiocyanate-phenol-chloroform 
procedure (Chomczynski and Sacchi, 1987); Northern or dot blot analysis was carried out as 
previously described (Alam et al., 1989; Alam et al., 2000). Briefly, for RNA dot blot analysis, 5 
ug of total RNA was transferred to a Zeta-Probe (Bio-Rad) nylon membrane using a Minifold l 
Filtration Manifold (Schleicher & Schuell) and for Northern blot analysis, 10 up of total RNA 
was fractioned on a denaturing formaldehyde-agarose (1%) gel (Maniatis et al., 1982) and 
transferred to a Zeta-Probe nylon membrane according to the manufacturer’s recommendations. 
p32-radiolabelehybridization probes were generated by random priming of the rat HO-1 or 
ribosomal protein S3 cDNA fragments. Vacuum-baked filters were incubated for 4 to 16 h at 
45°C with 10 ml of hybridization solution: 3X SSPE (1X SSPE = 0.15 M NaCl, l mM EDTA; 10 
mM sodium phosphate buffer; and pH 7.4) containing 40% (v/v) deionized formamide, 7% (w/v) 
sodium dodecyl sulfate (SDS), and 200μ g/ml denatured salmon sperm DNA. The filters were 
subsequently incubated with hybridization buffer containing the labeled DNA probe (specific 
activity: 2-10 x 108 cpm/ug, 1-10 x 107 cpm/ml solution) for 24 to 48 h at 45°C.  
After hybridization, the filters were washed with solutions of 2 X SSC (1 X SSC = 0.15 
M NaC1, 15 mM sodium citrate, pH 7.0) containing 0.1% SDS at room temperature for 30 
minutes and 0.1 X SSC, 0.1% SDS at 50°C (for heterologous probes) or 65°C (for homologous 
probes) for 60 min. The blots were then exposed to a phosphor-imaging screen for  
12 to 72 h at room temperature. HO-1 hybridization signals were detected and quantified using a 
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phosphorimaging device (Packard Instruments). After signal quantification, the membranes were 
striped and re-hybridized to the ribosomal protein S3 probe. Relative mRNA levels were 
calculated after correcting for the RNA loading by normalizing the primary hybridization signal 
with the ribosomal protein S3 signal. 
2.5.7 Protein Isolation and Blot Analyses  
Hepa, MEF/hsf-1+/+ (2 x 105 cells/60-mm plate) and MEF/hsf-1-/- (4 x 105 cells/60-mm 
plate) cells were seeded, cultured, and treated with chemical inducers as described above for 
RNA isolation, except that cell treatment, unless otherwise indicated, was carried out for 5 hours. 
Cells were subjected to hyperthermia (43°C) in complete media for 0.5 h. Where indicated, 
induction were added 30 min prior to addition of inducers. Western blot analyses were carried 
out using either whole cell extracts (WCE) or nuclear extracts. were electrophoresed on 4-12% 
gradient SDS-PAGE gels (Invitrogen), and proteins were transferred to polyvinylidene difluoride 
membranes. Antibodies were used at the concentrations recommended by the manufacturers and 
antigen detection was carried out using the ECL Plus Western blotting system (Amersham 
Biosciences) according to the manufacturer’s recommendation.  
2.5.8 Electrophoretic Mobility Shift Assay 
Hepa cells (1 x 106/100-mm plate) were seeded and cultured as described above for RNA 
isolation. Cells were treated with vehicle (water) or 80 μM ZnSO4 for 5 h in serum-free medium 
or subjected to hyperthermia (43°C) for 0.5 h in complete medium. In the preparation of cell 
extracts, the probe used for EMSA reactions was a double-stranded oligonucleotide 
corresponding to the hmox-1 E1+ HSE, 5’-GGCCGT GAAA GTTCT 
AGAAAGGCACAGAAGTTTCTT GTTTA-3’, (sequences corresponding to the consensus HSE 
are underlined). In antibody supershift assays, 1  (2 µg) of normal rabbit 1gG or specific rabbit 
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polyclonal antibodies against HSF-1 or Nrf-2 (Santa Cruz Biotech, Inc.) was added to the 
reaction mixture at room temperature 20 min prior to electrophoresis. Signals were detected and 
quantified using a phosphorimager (Packard Instruments). 
2.5.9 Preparation of Nuclear Extracts 
Hepa cells (5 x 106) were washed three times with cold, 8.5% phosphate-buffered saline and 
harvested by centrifugation at 1100 rpm for 10 min. The cell pellet was carefully resuspended in 
3-pellet volumes of cold buffer containing 20 mM HEPES, pH 7.0, 0.15 mM EDTA, 0.015 mM 
EGTA, 10 mM KCl, 1% Nonidet-40, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, 20 
mM NaF, 1 mM sodium pyrophosphate, and 1 mM Na3VO4. The homogenate was then 
centrifuged at 500 x g for 20 min, and the nuclear pellet was resuspended in 5-pellet volumes of 
cold buffer containing 10 mM HEPES, pH 8.0, 25% glycerol, 0.1 M NaCl, 0.1 mM EDTA, 1 
µg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, 20 mM NaF, 1 mM sodium 
pyrophosphate, and 1 mM Na3VO4. After centrifugation at 500 x g for 20 min, nuclei were 
resuspended in 2-pellet volumes of hypertonic cold buffer containing 10 mM HEPES, pH  8.0, 
25% glycerol, 0.4 M NaCl, 0.1 mM EDTA, 1 µg/ml leupeptin, 1 mM phenylmethylsulfonyl 
fluoride, 20 mM NaF, 1 mM sodium pyrophosphate, and 1 mM Na3VO4. The nuclei were then 
incubated for 30 min at 4°C . Nuclear debris was removed by centrifugation at 900 x g for 20 min 
at 4°C. One part of the supernatant was resolved by SDS-PAGE and submitted to immunoblot 
analysis using anti-Nrf-2  . The rest of the supernatant was used for electrophoretic mobility shift 
assay (EMSA). Protein concentration was determined with the Dc protein assay kit (Bio-Rad). 
2.6 Results2.6.1 HO-1 Expression Is Upregulated in a Dose-Dependent Manner by Exposure to 
Zinc  
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HO-1 regulation by zinc was evaluated. Hepa cells were assayed for baseline and zinc-
stimulated HO-1 protein and mRNA levels. Dose-dependent HO-1 production was observed 
after administration of increasing amount of ZnSO4 (Figure 2.2A). HO-1 mRNA levels were also 
dependent on the amount of zinc exposure (Figure 2.2A). Both protein and mRNA expression 
were highest around the same concentrations of ZnSO4, about 80 µM. Hepa cells were also 
transfected with pHO-15luc, and luciferase activity was quantified (Figure 2.2C.). Expression of 
the reporter construct in the transfected cells was augmented with increasing concentrations of 
ZnSO4. Luciferase activity was induced more than 25-fold at its peak response. 
2.6.2 Enhancer Regions, Along with StREs Located Within, are Required for Zinc-Induced 
Activation 
 
Constructs of pHO-15luc were made with deleted sequences, including the E1 and E2 
enhancer regions located upstream from the transcription start site on hmox-1. These regions 
contain motifs that are used as binding sites for transcription factors in other types of HO-1 
induction (Alam et al., 2000; He et al., 2001; Stewart et al., 2003). These plasmids were 
transfected into Hepa cells and the cell extracts were assayed for reporter activity (Figure 2.3). 
Deletion of either region alone significantly decreased luciferase activity induced by zinc, while 
deletion of both regions ablated the activity. Mutation of an unrelated region, B, did not affect 
transcription of the reporter. Previous studies have shown similar importance of these regions 
using different inducers such as proteasome inhibitors (Stewart et al., 2003). 
Further studies were carried out using cells transfected with plasmid constructs 
containing mutated motifs within E1. These constructs included three mutated StREs, a mutated 
HSE, or both ,But E2 doesn’t contain StrE ,and HSE which can be tested together this the reason 
I used E1 in this experiement.(Figure 2 4). Baseline levels of reporter transcription remained 
 31
relatively the same. Upon treatment with zinc, however, reporter expression was significantly 
altered. Cells that contained the nonfunctioning StREs demonstrated almost no luciferase 
activity, whereas cells with no HSE and intact StREs had normal zinc-induced HO-1 responses. 
These results differ from those seen in HO-1 induction by cadmium, which require the HSE 
(Stewart et al., 2003). 
2.6.3 HO-1 Expression Caused by Zinc Exposure Is Dependent upon the Transcription Factor 
Nrf-2 
To analyze whether Nrf-2 protein is expressed in the cytoplasm and then transported to 
the nucleus during oxidative stress, experiments similar to those described above were 
performed, except that cell extracts were separated into cytoplasmic and nuclear fractions. As 
shown in Figure 2.5, treatment of Hepa cells with 20-30 uM of ZnSO4 increased the level of Nrf-
2 protein in the nucleus within 1 h. However, Nrf-2 was not observed in the whole cell extract, 
even in uninduced cells (Figure 2.6A), suggesting an alternative mechanism for Nrf-2 protein 
expression, but one that could still require cytoplasmic-nuclear transport. 
2.6.4 HO-1 Expression Caused by Zinc Exposure Is Dependent upon the Transcription Factor 
Nrf-2 and Independent of HSF-1 
 
Since other studies have revealed that Nrf-2 and HSF-1 play important roles in HO-1 induction 
by heavy metals (Alam et al., 1999; Alam et al., 2000; He et al., 2001 ), these transcription 
factors may regulate this mechanism. Treatment of Hepa cells with increasing doses of ZnSO4 
caused greater expression of Nrf-2 (Figure 2.6A). As HO-1 production is primarily controlled by 
transcriptional regulation, Nrf-2 adjusted HO-1 expression in Hepa cells was examined. EMSAs 
were performed using olig5’GATCTTTTATGCTGTGTCATGGTTT3’, which showed the 




























Figure 2.2  Treatment with ZnSO4 Causes Protein Synthesis and in mRNA and HO-1. The effects 
of zinc on the protein levels of HO-1 .Hepa cells were maintained for 24 h in low serum medium 
and then stimulated with  ZnSO4 (0, 20, 40, 60, 80, or 100µM). B Hepa cells were incubated 
overnight,and HO-1 m RNA was normalized to S3m RNA ,and ratio HO-1/S3 m RNA are 
expressed as arbitrary densitometric unites under the blots and represented the average The right 
panel with anti-HO-1 antibody is a dose-dependent semiquantitative reverse mean ± SE (n=3) p> 
0.05 .transcription –PCR showing dose-dependent induction of HO-1 by zinc determination of 
HO-1 m RNA levels in the presence of  ZnSO4 and analyzed, as shown, under experimental 
procedure C. The indicated cells were transfected with a DNA mixture consisting of 3 µg of 
pE1-luc and 2µg p CMV-gal transfection. Induction and enzyme assay were carried out as 


































































































Figure 2.3  The E1and E2 regions of pHO-15luc are required for the activation of pHO-15luc 
Expression in cells treated with ZnSO4 (80µM).  Hepa cells were transfected with pHO-
15luc,incubated for 5h at 37°C, as well as mutants of the plasmid containing deleted E1, E2, 
E1/E2, and B sequences. Cells were then treated with ZnSO4 and the extracts were measured for 
luciferase activity relative to unstimulated pHO-15luc expression. Data are shown as the fold 














Figure 2.4  StREs are Required Alone. Within region, E1 is required in ZnSO4 in the induction of 
hmox-1. Mutant constructs of E1  hmox-1 were made by deleting the three StRE sequences, the 
HSE sequence, or the three StRE and the HSE sequences. Hepa cells were then treated with 
ZnSO4. (80 µM) for 5 h at 37°C. Cell extracts were then assayed for luciferase activity relative to 





by the addition of anti-Nrf-2 antibody, meaning Nrf-2 is binding regions on hmox-1 (Figure 2.6 
B). Direct binding of hmox-1 cis-regulatory elements by transcription factors showed that Nrf-2 
was definitely contributing to the regulation of HO-1. 
Similar experiments were performed looking at HSF-1 in zinc-induced HO-1 production. 
HO-1 was produced by Hepa cells when treated with cadmium, arsenite, and zinc (Figure 2.7A). 
However, unlike the other inducers, zinc did not cause greater expression of phosphorylated 
HSF-1. These data are congruent with earlier results showing that HSE is not required for zinc-
induced HO-1 expression. Further EMSAs were completed with oligo (Figure 2.7B). Treating 
the cells with heat shock, Cd, and As caused the formation of DNA-protein complexes, but zinc 
exposed cells did not. 







Figure 2.5  HO-1 Induction by ZnSO4 in Mouse Embryonic Fibroblasts is Expressed Through an 
Nrf-2-Dependent Mechanism (A, B) or Hepa cells treated with U0126 ERK1/2 inhibitor(C). A, 
B. Wild-type (WT) and ERK1 knockout (KO) MEF cells were exposed to the indicated 
concentration of ZnSO4 for 4 h. Western blot analysis was carried out as described in 
"Experimental Procedures" using whole cell (A, 20 μg protein/lane) or nuclear (B, 30 μg 
protein/lane) extracts and antibodies directed against the indicated antibodies. Cadmium-treated 
Hepa cell extracts were used as a positive control for Nrf-2 (+). C. Hepa cells were treated with 0 
(-) or 10 µM (+) U0126 for 1 h prior to treatment with 0 or 80 µM ZnSO4 for an additional 4 h. 
Western blot analysis was carried out using nuclear extracts (30 μg protein/lane) and anti-Nrf-2 
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Figure 2.6  Zinc Stimulates Nrf-2 Protein Expression (A) and StRE Binding Activity (B) in Hepa 
cells. A. Cells were exposed to the indicated concentration of  ZnSO4 for 3 h. Western blot 
analysis was carried out as described in "Experimental Procedures" using whole cell extracts (30 
μg protein/lane) and anti-Nrf-2 antibodies. The Nrf-2 positive control protein (+, lane 6) was 
generated by transfection of an Nrf-2 expression plasmid into Hepa cells. B. EMSA reactions 
using oligonucleotides corresponding to the mouse HO-1 sStRE and nuclear extracts from cells 
treated with 0, 40, 60, or 80 µM ZnSO4 the last two lanes correspond to cell extracts from zinc-
treated cells preincubated without(-)or with(+) anti-Nrf-2 antibody.The arrow head  points to the 
position of the complex that was not formed in the presence of anti-Nrf-2 antibodystars indicate 
specific binding..” 
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Figure 2.7   Heat shock elements HSE is not important in HO-1 induction by Zinc .in Transiently 
and Stably Transfected Cells. A.Hepa cells were either treated with a vehicle 50 µM CdCI2, 20 
µM NaAsO3 or 80µM ZnSO4 for 5 h, or exposed to 43°C heat shock for 30 min. Whole cells 
exctracts (20 g/lane) were subjected to immunoblot analysis for the indicated proteins. B.EMSA 
reactions were carried out using the mouse E1+ HSE probe and extracts prepared from Hepa 
cells that were either treated with vehicle, 50 µM CdCI2, 20 µM NaAsO3, or 80 µM ZnSO4 for 3 
h, or exposed to a 43°C heat shock for 30 min. The HSE:HSF complexes are marked by an 




2.6.5 Nrf-2 Knockdown Diminishes HO-1 Accumulation in Response to Zinc 
 
To more directly assess the role of Nrf-2 in zinc-mediated HO-1 induction, stable 
transfectants of Hepa cells expressing a short hairpin RNA (shRNA) that targeted the Nrf-2 
trranscript for RNAi mediated degradation were generated. The efficacy and specificity of the 
Nrf-2 shRNA were demonstrated by the significantly reduced accumulation of Nrf-2 protein, in 
response to zinc, relative to that observed in cells expressing the control shRNA, and by the lack 
of effect on the expression Nrf-2 Figure.2.8A). Importantly, Nrf-2 knockdown caused a 
significant reduction (>90%) in zinc-mediated HO-1 induction, demonstrating a role of Nrf-2 in 
such regulation. 
2.6.6 Induction of HO-1 Expression by Zinc in Mouse Embryo Fibroblasts Lacking  
HSF-1 
Experiments were performed looking at HSF-1 in zinc-induced HO-1 production. HO-1 
was produced by Hepa cells when treated with cadmium, arsenite, and zinc. However, unlike the 
other inducers, zinc did not cause greater expression of phosphorylated HSF-1. These data are 
congruent with earlier results showing that the HSE is  required for zinc-induced  
did not reduce HO-1 expression. Further EMSAs were completed with oligo (Figure 2.7b). 
Treating the cells with heat shock, Cd, and As caused the formation of DNA-protein complexes, 
but zinc exposed cells did not. 
Cells containing the reporter construct, pHO-15luc, and wild-type Hepa cells treated with 
Nrf-2, and control shRNA (Fig. 2.8A). The basal and zinc induced transcription was then 
measured by luciferase assays in the cells containing pHO-15luc. RNAi-mediated knockdown of 
Nrf2 diminishes HO-1 production,. The normal Hepa cells were also treated with two different 
Nrf-2 shRNA constructs, Nrf-2[192] Fig. 2.8B  
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As in Hepa cells, zinc treatment elicited a robust and dose-dependent accumulation of 
HO-1 protein in WT MEF cells (Fig.2.9). In KO MEF cells, however, both the basal and zinc-
induced levels of HO-1 were affected, although not totally ignored. By comparison, loss of HSF-
1 completely abrogates induction of Hsp70 as previously reported (Hatayama et al. 1992; 
Hatayama et al., 1993; Hatayama and Hayakawa, 1999). 
Thus, while induction of Hsp70 in MEF cells is entirely dependent on HSF-1, induction 
of HO-1 is completely dependent on this transcription factor. The phenotype of the MEF cells 
was confirmed by zinc-mediated inactivation of HSF-1 (i.e., reduced mobility) in WT cells and 
the absence of HSF-1 in KO cells. Furthermore, targeted deletion of HSF-1 does not affect zinc 
inducibility of Nrf-2. This result suggests that the reduction of HO-1 induction in KO cells is an 
effect is independent on the HSF-1. HSF-1 is dependent on HSP70 expressionn of Nrf-2 activity 
and at the same time provides acceptable mechanism for the residual expression of HO-1. 
and Nrf-2[437]. The whole cell protein extracts were then treated with shRNAs and were also  
assayed for Nrf-2 and HO-1 protein expression. The Nrf-2[192] treated cells showed diminished 
Nrf-2 and HO-1 expression, while the cells transfected with Nrf-2[437] showed no Nrf-2 and 
significantly less HO-1 (Figure 2.8 A and B ) 
The role of HSF-1 in HO-1 regulation in mouse embryo fibroblasts (MEF) derived from 
wild-type (hsf+/+) and HSF-1 knockout (hsf-/-) mice was investigated (Figure 2.9).  
2.7 Discussion 
2.7.1 The Major Finding of This Work  
































Figure 2.8  RNA I-Mediated Knockout of Nrf-2 Diminishes hmox-1 Induction by Zinc. A. Hepa 
cells stably transfected with the control (Conp 1. Conp.2)of Nrf-2 shRNA (Nrf-2-192, Nrf-437) 
expression plasmids were treated with vehicles(-)or 80 µM of zinc (+) for 5 h. B. Whole cell 










































































Figure 2.9  Lacking HSF-1 has no Effect on the Induction of HO-1 in Response to ZnSO4 in 
Mouse Embryo Fibroblasts. HSF-1 is not required for optimal induction of hmox-1 by ZnSO4 in 
mouse embryo fibroblasts. Embryonic fibroblasts from Nrf-2+/+(WT) and Nrf-2-/-(KO) mice 
were treated with 0, 10, 20, or 30µM ZnSO4 cell extracts (10 µg) wild-type (WT) and -to HSF-1-


























































and transfected HO-1 promoter-reporter constructs (Figures 2.2); HO-1 expression is upregulated 
in a dose-dependent manner by exposure to zinc; and HO-1 is induced by an abundance of 
materials, including many heavy metals. Hepa cells were assayed for baseline and zinc-
stimulated HO-1 protein and mRNA levels. Dose-dependent HO-1 production was observed 
after administration of increasing doses of ZnSO4 (Fig. 2.2 A). HO-1 mRNA levels were also 
relative to the amount of zinc exposure (Fig. 2.2A). Both protein and mRNA expression were 
highest around the same concentrations of ZnSO4, at 80 µM. Hepa cells were also transfected 
with pHO15luc and luciferase activity was quantified (Fig. 2.2C). Expression of the reporter 
construct in the transfected cells was augmented with the increasing concentrations of ZnSO4. 
Luciferase activity was induced more than 35-fold at its peak response. 
2.7.2 Identification of Sequence Elements Necessary for Gene Activation by Zinc  
Previous studies have demonstrated that two 5’ distal enhancer regions, E1 and E2, 
mediate mouse hmox-1 gene activation in response to multiple inducers including heme, 
cadmium, and 15-deoxy-∆ 12, 14 –prostaglandin J2 (Alam et al., 1999; Alam et al., 2000; He et al., 
2001). The role of E1 and E2 in ZnSO4 responsiveness was tested using mutant derivatives of 
pHO-15luc. Targeted deletion of a 521-bp fragment containing the 268-bp E1 enhancer (∆E1) 
inhibited ZnSO4 responsiveness by greater than 80%, whereas deletion of the 161-bp E2 
fragment reduced induction by only 10%, indicating a greater importance of E1 in this response.  
E1 enhancer region , however, are required for optimal induction, as deletion of E1   
(Figure 2.3A), completely abolished zinc responsiveness. The specificity of the E1 and E2 in this 
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response is demonstrated by the fact that deletion of sequences between -1.3 kb and -3.5kb (∆B) 
did not affect zinc-induced luciferase expression. 
The activity of the E1 region was examined in more detail because of its greater 
contribution to zinc responsiveness. E1, as originally defined, contains three copies of a sequence 
motif, termed the stress-response element (StRE), that are essential for transcription activation in 
response to multiple agents including heme. Arsenite, the StRE-binding protein implicated in 
these responses, is the transcription factor Nrf-2 (Alam et al., 2003). Additionally, a functional 
HSE was identified immediately downstream of the E1 enhancer (Alam et al., 2003; Stewart et 
al., 2003). Because Nrf-2 is subjected to proteasomal degradation (Alam et al., 2003; Stewart et 
al., 2003) and HSEs have been implicated in HO-1 expression by heavy metals (Alam et al., 
2003), it was reasoned that one or both types of elements may be responsible for hmox-1 
activation by zinc. To test this hypothesis, the original E1 enhancer was extended to include the 
HSE resulting in the 321-bp E1+ fragment. (Incidentally, both the StREs and the HSE are deleted 
in the ∆E1 derivative of pHO-151uc). Luciferase reporter constructs under the control of WT or 
mutant E1+ were stably transfected into Hepa cells and assayed for zinc inducibility. As shown in 
Figure 2.4, treatment of cells harboring the WT E1+ construct with 80 μM ZnSO4 increased 
luciferase activity by 12-fold over basal levels, whereas mutants lacking either the StREs {mutS} 
and {mutH}, exhibited significantly reduced induction by 80 %. While mutants lacking the 
{mutH} had no significant effect, no induction was observed with a mutant lacking both types of 
mutant response elements ({mut S},{mut H}). Since there is no StRE in E2 region, E2 plasmid 
construct not used. These results indicate that only the StREs are required for optimal hmox-1 
activation by ZnSO4.  
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2.7.3 Transcription Factors Potentially Responsible for hmox-1 Activation by Zinc 
The principal StRE-binding protein responsible for hmox-1 activation (by multiple 
agents) is the transcription factor, Nrf-2, and the best characterized as StRE regulators. To better 
understand the mechanism of hmox-1 activation by zinc, the effect of zinc on the expression of 
transcription factors in Hepa cells was examined. As shown in Figure 2.5C, zinc treatment 
promoted a  nuclear accumulation of Nrf-2. This factor was detected as early as 30 min and 
continued to increase up to the last time point tested (4h). This  is consistent with a role for Nrf-2 
in hmox-1 regulation, since an increase in cytoplasmic HO-1 was not detected until 3 h after 
initiation of zinc treatment (Figure 2.5B). Additionally, zinc-induced Nrf-2 is known to have 
StRE-binding activity (Stewart et al., 2003). Zinc treatment of Hepa cells did not  activate HSF-
1,  (Figure 2.7B). It is well-known that Nrf-2 is not the sole regulator of HO-1. Other 
transcription factors such as Maf (Alam et al., 2003)  contribute to HO-1 induction, and this 
explains why we have a lot of HO-1 at lower  zinc concentration Fig 2.6 in In addition, HO-1 
regulation by zinc in MEF cells was examined. Zinc treatment stimulated HO-1 expression in a 
dose-dependent manner in WT cells, but this response was not significantly altered in cells 
lacking HSF-1(Figure 2.8). Consistent with that observed in Hepa cells, zinc did not activate 
HSF-1 as judged by: 1) the absence of electrophoretic retardation, (Figure 2.7B) and 2) lack of 
Hsp70 (Figure 2.8)induction in MEF. These results corroborate the earlier conclusion that the 
HSE/HSF pathway is not involved in hmox-1 activation by zinc. 
2.7.4 Nrf-2 and StRE Mediate hmox-1 Gene Activation by Zinc 
 
Previous studies from our laboratory using a dominant negative mutant (DNM) of Nrf-2 
have implicated this transcription factor in hmox-1 activation by cadmium (Alam et al., 1999; 
Alam et al., 2000). Given the newl findings of StRE, and its role as a target for the transcription 
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factor, the role of Nrf-2, and also , on the induction of the E1+-luciferase fusion gene in response 
to zinc was investigated. Because of the limited specificity of DNMs, it was decided to inhibit or 
knock down Nrf-2 expression by RNA interference (RNAi) using several individual small 
hairpin RNA (shRNA) constructs made against Nrf-2 . Initial experiments tested the efficacy of 
these constructs. Nrf-2 shRNA constructs were tested for their ability to inhibit Nrf-2 
transactivation of a luciferase reporter under the control of three tandem copies of a StRE, 
p3xStRE-luc. In transient transfection assays using Hepa cells, co-expression of either of the 
shRNA/Nrf-2 constructs decreased luciferase activity by approximately 75%, with Nrf-2[192] 
demonstrating the most effective response (Figure 2.8A).  
The basal- and zinc-induced transcription was then measured by luciferase assays in the 
cells containing pHO15luc. RNAi-mediated knockdown of Nrf-2 diminished HO-1 production, 
while HSF-1 knockdown did not (Figure 2.9).  The normal Hepa cells were also stably 
transfected with two different Nrf-2 shRNA constructs, Nrf-2[192] and Nrf-2[437]. Whole cell 
protein extracts were then assayed for Nrf-2 and HO-1 protein expression. The Nrf-2[192] 
treated cells showed diminished Nrf-2 and HO-1 expression, while the cells transfected with Nrf-
2[437] showed no Nrf-2 and significantly less HO-1(Figure 2.8A). 
2.7.5 How Does Zinc Activate HO-1 Expression?  
The Keap 1-dependent model of Nrf-2 degradation provides a plausible mechanism. 
Recently, several groups have identified critical cysteine residues in Keap1 that are required for 
Keap1-dependent ubiquitinoylation of Nrf-2 and the Keap1-mediated repression of Nrf-2 
activation under basal conditions (Dinkova-Kostova et al., 2002; Levonen et al., 2003; Zhang 
and Hannink, 2003). Cysteine residues contain thiol groups that react with inducers by 
alkylation, oxidation, reduction, or thiol interchange ─ which results in modification of the 
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protein, such as the formation of disulfide bonds, and protein conformational change (Prochaska 
et al., 1985; Dinkova-Kostava et al., 2001). Mutation of these residues resulted in loss of 
repression of Nrf-2. In addition, selective cysteine residues (Cys257, Cys273, Cys288, and 
Cys297) were shown to interact with several inducers, including dexamethasone mesylate and 
15d-PGJ2. The cysteine residues in Keap1 appear to function as redox-sensitive molecular 
switches that react with inducers through their cysteine-thiol groups, resulting in the disruption 
of the Keap1-Nrf-2 complex and release of Nrf-2. Furthermore, zinc was  shown to bind to 
protein-sulfhydryl groups of MT and GSH molecules (Waisberg, 2003, Waalkes, 2003). Two 
possible mechanisms for Nrf-2 release are: 1) Zinc binds the thiol groups in the cysteine residues 
of Keap1, or 2) ROS generated by zinc oxidizes the thiol groups in the cysteine residues of Keap 
1. Both scenarios promote conformational changes in Keap1, resulting in release of Nrf-2. 
Finally, future work is required to answer questions, such as whether other antioxidants 
are more effective than zinc in stimulating Nrf-2 levels. This needs to be investigated, because 
there are less potent inducers of HO-1 mRNA. One explanation for this discrepancy is that the 
steady-state level of Nrf-2 is not the sole determinant of Nrf-2 activity. Such activity is likely to 
require post-translational modification, such as phosphorylation, which may occur optimally in 
response to zinc or other antioxidants. This possibility is supported by the observation that 
mutation of the StREs within E1 enhancer t completely abolish zinc-dependent transcription 
activity of the enhancer (Figure 2.4).  
Additional support is provided for a non-StRE/Nrf-2 model such as: the toxicity of zinc is 
associated with the promotion of cellular oxidative stress, either by enhanced production of ROS 
or inhibition of cellular antioxidant defenses. This imbalance in redox homeostasis is expected to 
alter protein conformation through various mechanisms, including modification of glutathione-
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protein mixed disulfide bonds and inter- and intra-protein-protein disulfide bonds (Senisterra et 
al., 1997; Zou et al., 1998b, Dinkova-Kostova et al., 2001). Accumulation of damaged and 
unfolded proteins would then activate HSF-1, as described previously. 
The preliminary data presented in this study suggests that the StRE motifs play an 
important role in the E1+ enhancer. In luciferase gene reporter studies, mutation of StREs and 
demonstrated their necessity and cooperativity in the transcriptional activation of hmox-1 gene 
by zinc. Additionally, RNAi knockdown studies and the use of Nrf-2 deficient  cells 
demonstrated that Nrf-2 and StRE are both necessary for E1+ activation and HO-1 protein 
expression by zinc. Taken together, the data suggest that cooperativity exists between StRE and 
Nrf-2. The synergistic effects of StRE and Nrf-2 could arise by several different mechanisms: 1) 
a direct interaction between transcription factors in which one or both interact with the 
transcriptional machinery, 2) no interaction between transcription factors but one or both interact 
with the transcriptional machinery, or 3) an indirect interaction between transcription factors via 
coactivator(s) in which interaction with the transcriptional machinery can occur through the 
coactivator or through Nrf-2 and StRE alone, together. These protein interactions can result in 
altered DNA-binding activities or transactivation properties (Lin et al., 1990; Chinenov and 
Kerppola, 2001; Courey, 2001).  
In summary, this study identified one of the conserved motifs in the E1 enhancer, the 
StRE that is involved in zinc-induced hmox-1 gene regulation. The data demonstrate that the 
StRE(s) appear to activate the hmox-1 gene in response to zinc. 
Analyses have led to three main findings: 1) the identification of a functional StRE in the 
5’ end of the E1 that binds to Nrf-2 in response to zinc, 2) the knowledge that both Nrf-2 and 
StRE are necessary and cooperate together in the transcription activation of the hmox-1 gene by 
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zinc, and 3) that not all HO-1 inducers utilize the HSE/HSF-1 pathway for activation. 
Collectively, these findings point to the possibility of an independent cellular heat shock 
response pathway that is responsible for hmox-1 gene regulation. This finding is consistent in 
one part with previous work done by Stewart et al. (2003) in which it was demonstrated that the 
conserved StREs within the hmox-1 E1 enhancer, in conjunction with the transcription factor 
Nrf-2, mediate gene activation in response to cadmium in several cell types including Hepa cells 
(Alam et al., 2000; He et al., 2001; Stewart et al., 2003). 
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3. ZINC-MEDIATED INDUCTION OF THE HEME OXYGENASE-1 GENE IN MOUSE 
HEPA CELLS BY THE EXTRACELLULAR – REGULATED KINASE (ERK1) 
3.1 Introduction 
3.1.1 Zinc and Signal Transduction 
The three classes of the  mitogen-activated protein kinase (MAPK) family are: extra 
cellular signal-activated protein kinases (ERK), Jun N-terminal kinases, and p38 MAP kinases. 
The kinases activated by cells exposed to zinc include protein kinases C (PKC) JNK, 
extracellular regulated kinase 1/2 ERK1/2, p38 kinases (Zhang et al., 1998; Seo et al., 2001; 
Kohda et al., 2006; Kim et al., 2007), tyrosine kinases, and casein kinases II (Masuya et al., 
1999). Support for the involvement of cellular protein kinases in the regulation of transcription 
factors comes from studies using inhibitors of various kinases. The studies showed that inhibition 
of PKC and MAPK/ERKs blocked zinc induced overexpression of c-Jun and c-Fos (Zhang, et 
al., 2001). 
 One of the approaches to study zinc and its relation to signal transduction pathways used 
glucose deficiency (GD ) induced cell death, which was demonstrated through regulation of 
ERK1/2. It was shown by switching the GD–induced necrosis to apoptosis by decreasing the 
ROS production through the action of superoxide dismutase (SOD), which was brought about by 
the inhibition of copper /zinc degradation. This led to activation of caspase 3 and caspase 9, 
which has a pro-apoptotic activity (Kim et al., 2007). In another study of the rat renal cortex, cell 
nuclear fractions appeared after zinc treatment, which caused an increase of 4-hydroxynonena (a 
well-known lipid peroxidation). Zinc increased the expression of pERK and pELK- in the 
nuclear fraction, which later suppressed by U0126 (p-ERK1/2) inhibitor (Kohda et al., 2006). 
In another study, a well known toxin, peroxynitrite, has been demonstrated  to play a 
major role in white-matter pathogenesis by using oligodendrocytes (OLs) as a primary cell 
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culture. Since it oligodendrocytes expresses the myelin basic protein, it has been shown that the 
maintaining intracellular zinc homeostasis prevents oxynitrite progression by inhibiting p-
ERK42/44 phosphorylation of ERK42/44, inhibiting activation of 12-lipoxygenase, and 
eliminating the accumulation of reactive oxygen species (Zhang et al., 2005). Zinc deficiency has 
also been proven to increase cellular proliferation: in a model for neuronal cells. When cells are 
incubated with low zinc media, the cell showed an increase in cell oxidants and hydrogen 
peroxide (H2O2), which increases JNK and p38 activation, high nuclear AP-1-DNA binding 
activity, and AP-1-dependent gene expression. However, the addition of the catalase reversed the 
reduction of cell proliferation (Zago et al., 2005). In another study, the oxidative role of zinc has 
been implicated by inhibition of the glutathione cuased by the intracellular zinc which causes an 
increase in the ERK1/2 activation in HT22 cells ( McLaughlin et al., 2001). Another study 
supporting the oxidative role of zinc found that zinc released from intracellular stores by MIT 
triggers the activation of ERK1/2; persistent ERK1/2 activation also is observed in glutamate-
induced oxidative toxicity in the HT22 neuroblastoma cell (Zhang et al., 2004). 
My goal in this chapter is to show which MAPKs are activated as a response to zinc 
induction and which ones are responsible for the upregulation of the HO-1 expression. I will be 
showing all theseobservations by using Lucifirase assay, by measuring the proteins level, using 
cell knock outs, and by using MAPKs inhibitors. 
3.1.2 Zinc-Mediated Induction of Heme Oxygenase-1 Gene in Mouse Hepa Cells by 
Extracellular-Regulated Kinase (ERK1)  
 
All of the previously mentioned studies have focused on demonstrating that zinc plays an 
important role in the signal transduction pathway(s), which has a profound positive impact on the 
oxidative stress response.  
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Redox-sensitive transcription factor NF-E2-related factor-2 (Nrf-2) has been 
demonstrated as the potential regulator of the stress response elements (StrE) (Nguyen, et al., 
2002). When there is no oxidative stress condition, Nrf-2 is in the cytoplasm binding to Keap-1 
(Itoh et al., 1999). Under oxidative stress condition, this complex is disrupted, thereby releasing 
Nrf-2, which subsequently translocates to the nucleus where it binds to other transcription factors 
such as Maf and Jun members (Hayes and McMahon, 2001). Phosphorylation and stabilization 
are required to liberate Nrf-2 from Nrf-2-Keap1 (Huang et al., 2002), and since the Nrf-2 has a 
half-life of 30 min, it becomes degraded by the ubiquitin-proteasome pathway (Alam et al., 
2002). 
In this study, the effect of zinc on the activation of signal transduction, and the signaling 
pathways leading to HO-1 expression was investigated. 
3.2 Experimental Procedures 
3.2.1 Materials  
The tissue culture media and gentamicin were from Invitrogen (Carlsbad, CA), and fetal 
bovine serum was obtained from Mediatech (Herndon, VA). Antibodies against transcription 
factors (Nrf-2) were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA), whereas 
anti-rat HO-1 was acquired from StressGen Biotech. Corp. (Victoria, Canada). Protease 
inhibitors were purchased from Calbiochem (San Diego, CA). Reagents for luciferase assays 
were acquired from Sigma Chemical Company (St. Louis, MO). All other chemicals were of 
reagent grade. 
3.2.2 Immunoblotting  
The 30 µg of cell lysate were resolved by SDS-PAGE and transferred to Immobilon-P 
membranes (Millipore Corp. Blots were analyzed with the appropriate antibodies (1:500), anti-
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ERK2 (1:1000), anti-p38 (1:1000), anti-Nrf-2 (1:16,000),  (Santa Cruz Biotechnology, Santa 
Cruz, CA); anti-phospho-Ser473 AKT1 (1:1000), anti-phospho-ERK2 (1:1000), anti-phospho-p38 
(1:1000), Inc., Beverly, MA); anti-phospho-JNK (1:1000) (Upstate Biotechnology, Inc., Lake 
Placid, NY); and anti-HO-1 (1:1000)  (Stressgen Biotech Corp., Victoria, British Columbia, 
Canada). Appropriate peroxidase-conjugated secondary antibodies (1:10,000) were used to detect 
the proteins of interest by enhanced chemiluminescence.  
3.3 Results 
3.3.1 Several MAPK Signaling Pathways Are Employed During Zinc-Induced hmox-1 
Expression  
MAPK signaling pathways are used during many different types of cell activity. Different 
transcription factors are activated by various combinations of these kinases. The action of MAPK 
signaling pathways, which consists of the phosphorylation  cascade of several kinases and 
proteins, has been implicated in hmox-1 expression by several inducers. This study explored 
several of the main players including ERK1/2, JNK, p38, and AKT. AKT, a serine/threonine-
specific kinase, is phosphorylated by PI-3K. Cells were treated with zinc for increasing amounts 
of time and then measured for expression of the kinases, as well as their respective 
phosphorylated forms (Figure 3.1). Phosphorylation of ERK, JNK, and p38 all appear to increase 
with time of zinc exposure, and these phosphorylated before the induction of HO-1. 
Dominant negative mutants (DNM) of several intracellular signaling molecules were 
created and transfected into cells along with the reporter plasmid. These cells were then treated 

















Figure 3.1 Effect of  Zinc on phosphrylation  of protein kinases Induction of HO-1 by Zinc. Map 
kinases beside P1-3K are activated in Hepa cells. Hepa cells were incubated for 24 h.  ERK, 
phosphorylated ERK(P-ERK),p38 and phosphorylated o-p-38 (p-38) ,c-Jun ,N-terminal kinase 
(JNK) and phosphorylated c-Jun N-terminal kinase (p-JNK) proteins were detected by western 
blotting. MAPKS are activated by dual phosphorylation of threonine and tyrosine residues 
located in the ‘activation lip’of the conserved core kinase sequence, the activated species (p-p44, 



































Figure 3.2.  Effect of MAPK and PI-3K Inhibitors on Induction of HO-1 by Zinc. (A) Hepa cells 
were maintained in a low serum medium for 24 h and then were pre-incubated with UO126 
(ERK1/2 inhibitor), 40 µM LY294002 (p38-specific inhibitor), 5 µM SB203580 (AKT-specific 
inhibitor), or 10 µM SP600125 (a C-junk inhibitor) for 15 min. Map kinases beside PI3K 
activated in Hepa cells. Hepa cells were incubated for 24 h and ERK, phosphorylated ERK(P-
ERK), p38 and phosphorylated o-p-38 (p-38), c-Jun, N-terminal kinase (JNK) and 
phosphorylated c-Jun N-terminal kinase (p-JNK) proteins were detected by western blotting. (B)  
Hepa cells were maintained in low serum medium and submitted to 80 µM ZnSO4 for 3 h. 
ZnSO4 treatment induced luciferase activity in the mouse HO-1 promoter in the presence of the 
MAPK and PI-3K inhibitors. 
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Figure 3.3  The Involvement of ERK1 Rather than AKT orPI-3K in Zinc-Mediated –hmox-1 
Induction. In serum-free medium, cells were exposed to vehicle (DMSO) or the indicated kinase 
inhibitor in for 1h prior to addition of 0 or 80 uM ZnSO4. Cells were incubated for an additional 
4 h and then processed for immunoblot analysis. Twenty or 80ug (P-AKT) of total cell extract 
were used for SDS-PAGE .A representative blot from 2-3 experiments is shown in.B. The 
induction of HO-1 expression of the unattenuated by the dominant-negative PI-3K and AKT 
dominant-negative mutants (DNM) of several intracellular signaling AKT and PI-3K caused 
molecules to be created and transfected into cells along with the reporter plasmid. These cells 
were then treated with zinc and tested for luciferase activity. (mean ± SE, n=5, p<0.01). 
 
 
3.3.2 ERK1 Alone Is Enough for hmox-1 Induction 
A requirement for active ERK1/2, but not protein PI-3K and AKT has been shown in Figure 3.3 
A and B. Moreover, the long-term oxidant effect of zinc, partially blocked by ERK1 or HO-1 
 54
inhibitors Fig 3.3A, further demonstrated that zinc attenuates oxidative stress through a pathway 
that involves ERK1 and HO-1 (Figure 2.5A) 
Another western analysis was performed in which antibodies against P-ERK1/2 alone 
completely diminished the HO-1 induction (Figure 3.3A). This was done to clear the previous 
result, which had shown some kind of non-specific binding of the anti-p-PI-3K and AKT.  
3.3.3 Involvement of the ERK Signaling Cascade in Zinc Induction of hmox-1 
To investigate the role of ERK1/2 in zinc induction of HO-1, several ERK pathway components 
(activated, ERK1 activated negative, ) were co-transfected with pHO-15Luc, then left untreated 
or treated with zinc. If the ERK was important for zinc signaling, an activated component of the 
pathway would increase luciferase gene activity in the absence of zinc, while the negative would 
block the ability of zinc to induce luciferase activity from the reporter gene. As shown in Figure 
3.4A, activated ERK1 increased luciferase gene activity, indicating each component led to 
induction of gene expression. 
3.3.4 HO-1 Expression Caused by Zinc Exposure Is Dependent upon the Transcription Factor 
Nrf-2 and the Activation of ERK1  
Since other studies have revealed that Nrf-2 and HSF-1 play important roles in HO-1 
induction by heavy metals (Alam et al., 1999; Alam et al., 2000; He et al., 2001; Stewart et al., 
2003), it was investigated as to how these transcription factors may be regulating this 
mechanism. Treatment of Hepa cells with increasing doses of ZnSO4 caused greater expression 
of Nrf-2 (Figure 2.6A). As HO-1 production is primarily controlled by transcriptional regulation, 
it was examined as to how Nrf-2 adjusts HO-1 expression in Hepa cells. EMSAs were performed 
using oligo 5’GATCTTTTATGCTGTGTCATGGTTT3’, which showed the formation of 
specific DNA-protein complexes. The movement of these structures was slowed by the addition 
of anti-Nrf-2 antibody; meaning Nrf-2 is binding X regions on hmox-1 (Figure 2.6B). Direct 
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binding of hmox-1 cis-regulatory elements by transcription factors showed that Nrf-2 definitely 
contributes to the regulation of HO-1. 
Next, the nuclear levels of zinc-induced Nrf-2 protein were analyzed. As shown in Figure 
3.4B, zinc and ERK1 showed a strong accumulation of Nrf-2 in the nucleus (Figure 3.4B,C) 
where the level increase is ERK1-dependent, since it has been not blocked by the specifice 
inhibitorr,this makes think that ERK1 is not the only regulater of the Nrf-2.  to verify the 
functional relation of the Nrf-2 binding to the HO-1 StRE, Hepa cells were contransfected with 
pHO-15luc, and expression vector for dominant negative mutant (DNM)  AKT, (DNM)   PI-3K 
and ERK-1  hmox-1 was significantly decreased in the dominant-negative ERK1. These findings 
suggest that the major role of ERK1, in the zinc–induced HO-1 (Figure 3.3A, B). 
3.4 Discussion  
3.4.1 Induction of Transfected hmox-1 Promoter Luciferase Reporter Constructs by Zinc 
In this study, the pathways that contribute to the increase in hmox-1 regulation by zinc 
were investigated. The search for the specific MAP kinase that is responsible for the 
upregulation of hmox-1 was also.  First, it was found that zinc upregulated hmox-1 by increasing 
the Nrf-2 level in nucleus and increasing the ERK1, which targets the Keap-Nrf-2 complex in the 
cytoplasm. This triggers the release of Nrf-2 and increases its concentration in the nucleus, where 
it binds to its target, the StREs in the E1 region located in the mouse. hmox-1 gene promoter, at 
least one of the two factors needed for the mediation, increases the Nrf-2 protein levels in 
coordination with the increase in the ERK1. This is the first time that a specific and detailed 
indication of which MAP kinase upregulates hmox-1 by zinc, even though it is well-known that 
zinc induces hmox-1. 
3.4.2 Extracellular Signal Regulated Protein Kinase1 (ERK1) Is Required for hmox-1 Induction  
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It is well-known that ERK1/2 activation plays a major role in cell survival, proliferation, 
and differentiation (Xia et al., 1995) during cell injury. For instance, Cheng et al. (2006) show 
that, under oxidative stress in neural cells, ERK1/2 is the major player in inducing apoptosis after 
using a biocide methylisothiazolinone (MIT), which increases the zinc concentration via the 
oxidation of cellular thiols (Du et al., 2002). In another study, it has been demonstrated that 
ERK1/2 activation can be caused by another pathway; that is, glutathione depletion has been 
mediated by intracellular zinc release in the HT22 cells. These present some models of cell death 
by ERK1/2 (McLaughlin et al., 2004; Zhang, 2004). 
These results show that, despite the fact that ERK1/2, p38, PI-3K, and JNK are activated 
by increasing the zinc concentration, they are involved to some extent in the induction of HO-1 
in Hepa cells. For example, ERK1/2 is very important for HO-1 upregulation (Figure 3.2A and 
B), whereas, inhibition of JNK, p38, and PI-3K have minimal effect on zinc-induced HO-1 
(Figure 3.2A). 
These findings are similar to those of others who have searched for the specific down 
stream kinase that controls the increase in HO-1 induction. When a dominant-negative version of 
the PI-13K was used, AKT and ERK1, only a slight decrease in the HO-1 promoter was 
observed in the PI-3K and AKT dominant negative mutant (DNM) (Figure 3.3A). This finding 
agrees with other findings, where they used food phytophenols (carnosol) in PC12 cells 
(Numazawa et al., 2003). Other findings that did not agree used (DNM) JNK in HO-1 (Alam et 
al., 2000). .  
A p38 inhibitor (SB 203580) (SB), and  JNK-c inhibitor ( SP600125 ) were able unable  
to block most of the zinc-mediated induction of HO-1at the same time they didn’t decrease the 
HO-1 level of expression . In contrast, for the ERK1/2  pathway inhibitor, (UO126) ,activated 
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components were able to induce HO-1 gene expression Fig 3.2A and dominant negative AKT 
components were unable to block zinc induction.but mutated ERK is able to abolish HO-1 (Fig 
3.2B). These experiments implicate a role for the ERK and at least an element 
3.4.3 Transcriptional Regulation of hmox-1 Expression by Zinc in Cytoplasm and Nucleus 
Cytoplasmic and Nuclear Nrf-2 Protein 
 
To investigate the potential Nrf-2 translocation through MAPK pathways, ERK1 KO 
MEF cells( Fig 2.5A) ,but ERK-2 is detected since the cells are ERK1.KO.MEF ),In the next 
step I was able to detect Nrf-2  in both cytoplasm and nuclear extract in cells that were exposed 
to the indicated concentration of ZnSO4 for 4 h. Hepa cells were treated by zinc for 5 h in the 
presence/absence of inhibitor (UO126) (Nrf-2 translocation is an upstream event for HO-1 
expression), in whole cells  and nuclear fractions were prepared for western blot analysis. As 
shown in Figure 2.5B and C , the Nrf-2 protein level in fractions remained unchanged following 
the incubation with zinc, MAPK signaling pathway inhibitor(UO126) . However, zinc evidently 
promoted Nrf-2 translocation into nuclei through the action of ERK1 (Fig 2.5A). 
3.4.4 ERK1 KO and UO126 
Zinc evidently promoted Nrf-2 translocation into nuclei, as demonstrated by the relatively no 
nuclear Nrf-2 expression in both the ERK1 knockout KO MEF cells and in the zinc-treated Hepa 
cells.(Fig 2.5 B,C) This expression was higher than in untreated Hepa cells. Zinc-induced Nrf2 
translocation was not blocked by the UO126. 
These results have shown the profound role that ERK1 plays in the activation of hmox-1 
zinc, since the inhibitors of P38 (SB203580), AKT specific inhibitor (LY200496), and a C-JNK 
inhibitor (SP600125) have no effect on HO-1 activation (Figure 3.3), while the ERK1 inhibitor 
UO126 completely diminishes hmox-1 activation (Figure 3.2). Moreover, confirmation about the 
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role of the ERK1/2 results indicate that ERK1 is the major MAPK responsible for zinc-induced 
HO-1 (Figure 2.5A) is due to cross reactivity of the AKT inhibitor; (LY200496) a, similar 
finding on arsenite-induced HO-1 in rat hepatoma cells (Kietzmann et al., 2003). p38 has been 
shown to have a major role in the arsenite induction of hmox-1 using the LMH chicken hepatoma 
cell line (Elbirt et al., 1998). 
The extracellular signals coupled through the conserved proline–directed serine threonine 
kinases MAPKs by serial phosphorylation cascade (Torres and Forman, 2003). As mentioned 
previously, Nrf-2 is a member of the Cap’n’Collar family of basic leucine transcription factors, 
and plays an essential role in the StREs phase II detoxifying enzymes and stress-inducible genes 
(Alam et al., 2000). Previous work on oxidant research has suggested that MAPK is a central 
pathway involved in Nrf-2 activation and translocation for highly-specific protein synthesis, 
including most readily inducible hmox-1 (Calabrese et al., 2005). These results showed that the 
ERK1 signal plays an important role, which is involved in Nrf-2 translocation from the 
cytoplasm into the nucleus and HO-1 induction by zinc. This is, to some extent, is similar to the 
Diallyl sulfide- treated –HepG2 (Gong et al., 2004) and ethanol-treated HMC-1 cells (Jeong et 
al., 2005). To clarify, it was demonstrated that the ERK1 signal is the major factor responsible 
for hmox-1 upregulation, even though other signals downstream also have a role in HO-1 
induction. It is a well-known idea that MAPK can be differentially regulated by the same stimuli 
in diverse cell types. The ERK pathway is thought to mediate cellular responses to growth and 
differentiation factors, whereas JNK and p38 enzymes are activated by distinct and overlapping 
sets of stress-related stimuli (Alam, et al., 2000). The small expression (artifact) indicated that 
other signaling pathway(s), tyrosine kinase, and phosphatidylinositol 3-kinase pathways are 
justified by the nonspecific binding of the p-PI-3K/akt  to the ERK1/2.(Fig 3.3). 
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Finally, it is concluded that the incubation of mouse Hepa cells with zinc induce 
oxidative damage, which increases the ROS, thereby activating the ERK1/Nrf-2. An assay to 
determine this kind of protection (for example, in measuring the liver enzyme and/or the HO-1 
activity caused by the high zinc content in the seafood) will be helpful. 
In this study, the ability of zinc to increase transcription of endogenous HO-1, and the 
activity of transfected luciferase reporter gene constructs under control of the HO-1 promoter was 
investigated. Transient transfection assays were used to investigate the mechanism of zinc-
mediated HO-1 gene expression. In mouse Hepa cells, the activities of MAP kinases, ERK, JNK, 
and p38 were increased by treatment with zinc. Activation of MAP kinases correlated with zinc-
mediated induction of endogenous HO-1 mRNA expression. Activated components of the ERK1 
kinase signaling pathway increased gene expression from an HO-1 promoter-driven luciferase 
reporter gene construct. An ERK1 inhibitor, a MEK inhibitor, and   the ERK kinase pathways 
blocked most of the zinc-mediated induction of HO-1.  
In contrast, for the JNK pathway, p38, and PI-3K activated components were unable to 
induce HO-1 gene expression but their inhibition did decrease HO-1 expression were JNK E p38 
and PI-3K inhibitors unable to block zinc induction. HO-1  reporter. These experiments 
implicate a role for the ERK1, and at least one Nrf-2, in the zinc-mediated induction of hmox-1 
genes (Fig2.5). 
These results indicate that zinc activates HO-1 expression, probably by translocation  of 
the Nrf-2 protein in an ERK1-dependent manner (Figure 2.5A, B). Therefore, in addition to its 
oxidant nature, zinc activates the ERK1 survival pathway and upregulates expression of HO-1. 
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4. GENERAL DISCUSSION 
4.1 Heme Oxygenase-1  
HO-1 catalyzes the initial and rate-limiting step in heme catabolism, thereby generating 
equimolar quantities of iron, carbon monoxide, and biliverdin, which is metabolized further to 
bilirubin by biliverdin reductase (Choi and Alam, 1996; Elbirt et al., 1999; Montellano, 2000; 
Otterbein and Choi, 2000;Stewart et al., 2003). HO-1 is an important inducible enzyme with 
antioxidant and cytoprotective activities that works against oxidative stress in response to heme 
and also to various stress stimuli, such as arsenite, carnosol, and cadmium (Alam and Cook, 
2003, Stewart et al., 2003). The cytoprotective functions of HO-1 depend on the activities of the 
reaction products (antioxidants biliverdin and bilirubin) and on the inducibility of HO- 1, which 
is regulated at the gene transcription level by two distal enhancers, E1 and E2 (Stewart et al., 
2003). Identification and analysis of the enhancers resulted in the discovery of multiple StREs, 
which are essential and sufficient for hmox-1 gene regulation by most inducers, including heme, 
cadmium and arsenite (Choi and Alam, 1996; Alam et al., 1999; Alam et al., 2000; He et al., 
2001; Alam and Cook, 2003; Stewart et al., 2003; Chou, 2005). In this study, zinc activated the 
E1 enhancer to a greater extent and exhibited higher inducible transcription activity than E2. 
This suggests that E1 is crucial in hmox-1 gene activation.  
Additionally, studies identified Nrf-2, a CNC-bZIP transcription factor, as a dominant 
regulator that mediates inducer-dependent regulation of the hmox-1 gene via the StRE motifs in 
response to several inducers including cadmium (Alam and Cook, 2003). However, the 




4.2 Regulation of Nrf-2 Activity Before this study, accumulating evidence indicated that Nrf-2 
was regulated, in part, by 
subcellular compartmentalization in the cytoplasm, and that it was transported to the nucleus 
after stimulation by stress agents to activate target genes (Itoh et al., 1999; Kobayashi et al., 
2002; Sekhar et al., 2002; Zipper and Mulcahy, 2002; Stewart et al., 2003). In unstimulated cells, 
Nrf-2 is inactive and sequestered in the cytoplasm in part, or in total, as the result of binding to a 
cytoskeleton-associated protein Keap1 (Itoh et al., 1999; Dhakshinamoorthy and Jaiswal, 2001; 
Kobayashi et al., 2002; Sekhar et al., 2002; Zipper et al., 2002; Stewart et al., 2003). Keap1 
contains an N-terminal region (NTR), a broad complex, Tramtrack, Bric-a-Brac/ poxvirus and 
zinc finger (BTB/POZ) domain, intervening region (IVR), a double glycine region (DGR) or 
Keich repeats, and the C-terminal region (CTR) (Figure 4.1) (Stewart et al., 2003; Itoh et al., 
2004). As Stewart (2005) further stated: 
Nrf-2 and Keap1 interact through the N-terminal Neh2 domain of Nrf-2 and several regions of 
Keap1 including the IVR, DGR, and CTR. Once stimulated by oxidative stress promoting 
agents, like zinc, Nrf-2 is liberated from Keap1 suppression, which allows Nrf-2 to translocate to 
the nucleus and activate target genes, like hmox-1. It is well known that important transcription 
factors are bound and repressed by inhibitory proteins as observed, for example, with the NF-
kB/lkBa system (Weissman, 1997; Destero et al., 2000).  (p. 122)  
 
However, initially it was discovered that the steady-state level of Nrf-2 protein increases 
upon exposure to zinc as a result of ERK1 activation. Furthermore, it was observed that Nrf2 
translocation was in the nucleus, not the cytoplasm, in response to zinc. This suggested an 
alternative mechanism during oxidative stress as presented in this model. In fact, the most 




 Figure 4.1 Potential Model 
for Zinc-Induced hmox-1- in Mouse Hepa Cells. 
Enhanced oxidation of zinc in the hepa cells with  physiological concentrations of afforded 
protection against glutathione depletion in response to moderately oxidized, electrophilic agents 
and hypochlorous acid. I subsequently established that moderately oxidized zinc rapidly 
stimulates phosphorylation of primarily  ERK1/2, p38, MAPK, and c-jun-N-terminal kinase 
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This needs to be investigated first by decreasing the rate of Nrf-2 degradation by the ubiquitin-
proteasome pathway. The second potential pathway is that, in response to oxidants like zinc, 
Nrf2 stability occurs by escaping recognition and degradation via the ubiquitin-proteasome 
pathway These are  just my assumptions and further work needs to be done regarding the 
separation the two potential pathways . 
 Stewart (2005) states, 
Interestingly, the mechanism that regulates Nrf-2 degradation appears to be linked to the 
Keap 1-dependent subcellular compartmentalization pathway. Support for this role comes 
from studies showing that Keap1 functions not only to sequester Nrf-2 in the cytoplasm, 
but also to actively increase the rate of proteasomal degradation of Nrf-2 by directly 
interacting with an ETGE motif within the N-terminal Neh2 domain of Nrf-2 (Figure 
3.1.) (McMahon et al., 2003; Itoh et al., 2003). Oxidative stress antagonizes this 
interaction resulting in the release of Nrf-2 protein and its translocation into the nucleus. 
(p. 124 ) 
As described in Chapter 2, research by McMahon et al. (2003) identified the Neh2 
domain of Nrf-2 as the degron sensitive to oxidative stress. Degrons are binding sites for 
ubiquitin ligases. The Neh2 degron is located in the N-terminus of Nrf-2 within the 
transcriptional activation domain and near the Keap1 binding site. Recently, several groups 
showed that Keap1 functions under basal conditions to negatively regulate Nrf-2 by acting as an 
adaptor protein for the Cullin3-Roc1 E3 ubiquitin ligase though its BTB and IVR domains 
(Stewart et al., 2003; Cullinan et al., 2004; Kobayashi et at., 2004; Zhang et al., 2004; Furukawa 
and Xiong, 2005). The Keap1-Cullin-Roc1 complex promoted ubiquitinylation of Nrf-2 and the 
subsequent degradation by the 26S proteasome in the cytoplasm. Furthermore, Zhang et al. 
(2004) demonstrated that seven lysines in the Neh2 domain of Nrf-2 are the primary 
determinants of Keap1-Cul2-Roc1-dependent ubiquitinylation of Nrf-2. The ubiquitin-
conjugating enzymes involved in the ubiquitinylation process during basal conditions are known; 
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however, the Nrf-2 binding site remains unknown (Stewart et al., 2003). McMahon et al. (2004) 
identified a DIDLID element in the Neh2 domain of Nrf-2 that appears to be necessary for 
recruiting a ubiquitin ligase. In addition to the Neh2 degron required for degradation of Nrf-2 
under basal conditions, a redox-sensitive degron, Neh6, was identified during oxidative stress 
(Stewart et al., 2003; McMahon et al., 2004). Although the Neh6 degron has been identified, the 
ubiquitin-conjugating enzymes involved in the ubiquitinylation process remain unknown. 
Furthermore, Nrf-2 appears to harbor other degrons because inhibition of both the Neh2 and 
Neh6 domains left a fairly short protein with a half-life of 2 h. According to Stewart et al. 
(2003), in the original Nrf-2-Keap1 model, cytoskeletal protein Keap1 was thought to sequester 
Nrf2 in the cytoplasm by binding to the actin skeleton, where it targets Nrf-2 for ubiquitin-
proteasome mediated degradation. Recent work by Velichikova and Hasson (2005), however, 
identified a nuclear export sequence (NES) in Keap1 and demonstrated that Keap1 sequesters 
Nrf-2 in the cytoplasm, not by binding to the actin cytoskeleton, but via an active Crm1/exportin-
dependent nuclear export pathway (Figure 4.1) (Stewart et al., 2003). 
Velichikova and Hasson (2005) suggested that because Nrf-2 has a nuclear localization 
sequence (NLS), the Keap1 NES exports Nrf-2 to the cytoplasm for ubiquitin-mediated 
degradation and prevents accumulation of Nrf-2 in the nucleus and activation of target genes 
under basal conditions (Stewart et al., 2003). Support for this role is derived from recent research 
showing that Nrf2 contains both an NLS and an NES (Stewart et al., 2003; Jain et al., 2005; Li et 
al., 2005;). Stewart (2005) also stated, 
Finally, Zhang and colleagues (2005) demonstrated that, during oxidative stress, Keap1 is 
ubiquitinylated by the same Cul3 complex that ubiquitinylates Nrf-2, but that it is 
degraded independently from the proteasome. The mechanism that targets Keap 1 for 
proteasome-independent degradation needs to be studied in the future. (p. 125)  
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4.3 Important Findings of Current Work 
This dissertation research involved a detailed investigation on the mechanism in which 
ERK1/Nrf-2 transduction pathway in Hepa cells stimulated by zinc, as well as the identification 
of a particular MAPK ERK1 and StRE in the E1 enhancer involved in zinc-dependent activation 
of the hmox-1 gene.  
Here, I summarize the important findings are summarized. During the investigation 
designed to characterize Nrf-2 activation, it was noted that various HO-1 inducers increased the 
steady-state level of the Nrf-2 protein.  In an effort to understand the increase in Nrf-2 protein 
expression, it was shown that Nrf-2 translocation to the nucleus is dependent on ERK1, and the 
key function of the ERK1 is to precisely control the activity of the Nrf-2 in order to upregulate 
hmox-1.  Furthermore, inhibition of Nrf-2 induction using ERK1 KO, MEF cells, abolished zinc-
stimulated activation of Nrf-2 and, subsequently, its binding to a StRE oligonucleotide. 
Inhibition of Nrf-2 did not completely inhibit zinc-induced HO-1 mRNA accumulation, which 
demonstrates that hmox-1 gene activation is only dependent on increased Nrf-2 protein 
expression.  However, studies from our laboratory have shown that mutation of all three StREs 
in the E1 region does not completely abolish induction of a luciferase reporter construct by 
cadmium treatment (Alam et al., 2000; Stewart et al., 2005, unpublished data).  Additionally, 
ectopic expression of an Nrf-2DNM does not completely inhibit activation of the hmox-1 gene or 
the E1-controlled luciferase gene by cadmium and zinc in several cell types, including Hepa cells 
(Alam et al., 1999; Alam et al., 2000; He et al., 2001, unpublished data). These studies suggest 
that Nrf-2 may not be the sole regulator of zinc-dependent hmox-1 gene activation and that other 
transcription factors and cis-acting DNA elements may be involved in hmox-1 gene regulation. 
4 Implication the Role of MAPK ERK1 and its Impact on Nrf-2 
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HO-1 induction by zinc. Furthermore, the ERK pathway is mainly responsible for zinc-
derived HO-1 induction, while another MAPK (S) is mainly responsible for zinc upregulation of 
HO-1 induction. In addition, it was found that UO126 ERK1 inhibitor showed higher HO-1 
inhibiting effects in zinc-treated  Hepa cells  than  untreated Hepa cells. Hence, findings suggest 
that HO-1 is induced mainly through the ERK pathway under normal conditions and zinc 
incubation, rather than through the PI-3K pathway under zinc incubation or multi-pathways. 
Interestingly, UO126 showed almost the same inhibitive effect on zinc-induced Nrf-2 
translocation. This apparent discrepancy is due to inhibitors nonspecific binding that other 
signaling pathways, such as protein kinase C, tyrosine kinase, and PI-3K pathways, which might 
also mediate zinc-derived Nrf-2 translocation to induce HO-1 expression  for regulation of Nrf-2.  
4.5 Implication of HO-1 Induction by Zinc and the Role of ERK1 
Previous work done on antioxidants has shown that there is an activation of MAPK in 
response to an antioxidant. For example, Cheng et al. (2006) demonstrated that HO-1 induction 
in response to Alpha-lipoic acid (ALA) is a natural oxidant that phosphorylates P44/42 MAPK 
pathways and increases HO-1 expression in A10 cells. In another study (An et al., 2004), 
ERK1/2 and other MAPKs accumulated in SH-SY5Y cells of Alzheimer’s disease (An, 
Bjorkdahl et al., 2005). Furthermore, Yao et al. (2007) demonstrated that flavonoids, including 
quercetin, protected human hepatocytes from ethanol-induced oxidative stress by ERK1/2, which 
translocates the Nrf-2 into the nucleus and induces HO-1 (Yao et al., 2007). 
In the events immediately following ERK1 activation by zinc, which acts on the Nrf-1-
Kelch complex,  it was oberved that the initial activation of ERK1 played an important role in 
the increase─most likely through phosphorylation (Pearson  et al., 2001). This needs to be 
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investigated later. It was also observed that Nrf-2 played an essential role in zinc–mediated HO-1 
induction. Other factors need to be identified, and questions need to be answered  
The magnitude of the ERK1 signal and its transient nature have been well known about 
the  extracellular signal-regulated kinases (ERKs), which are characterized by the TEY 
consensus sequence in the activation loop. The signal is activated by many factors during cell 
proliferation and differentiation (Pearson et al., 2001; Murphy et al., 2006). Furthermore, 
MAPKs signals are very heterogeneous, since ERK1 has a specific function─ 
phosphorylation/dephosphorylation of transcription factors. In these studies, ERK1,Nrf-2 has a 
critical characteristic. For example, Nrf-2 is translocated to the nucleus, findings demonstrate the 
common function of ERKS after being in the nucleus during phosphorylation of the Thr and Tyr 
residues at the TXY motif (Pearson  et al., 2001). After this, ERK1 can phosphorylate many 
transcription factors and, subsequently, these factors regulate the expression of many genes 
(Shen et al., 2006). 
These findings agree wih my findings; when I used the ERK1 KO, there was a significant 
reduction in the HO-1 expression ,compared to the wild type Fig 2.5A. Previous investigations of 
ERK signals have shown that the signals are transient, which implies that the down-regulation of 
the ERKs is controlled by dephosphorylation (Farooq  et al., 2004). 
Taking all these facts into account, it was concluded that the findings are real. Other 
factors contributing to Nrf-2 activation should be studied further to determine if other factors 
contribute to ERK1 signals in terms of phosphorylation and dephosphorylation.  
In summary it can be concluded, in comparison to the findings of others, that incubation 
of mouse Hepa cells with zinc increases HO-1 induction and mediates the zinc effect via ERK1 
via  ERK1/Nrf-2 transduction. 
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.4.6 Implication of Cooperativity between Two Pathways in hmox-1 Regulation 
The preliminary data presented have suggested cooperation between Nrf-2-StRE and Nrf-
2-ERK1 in the motifs of the E1+ enhancer and the MAPK ERK1 in response to zinc.  Having 
these two major factors activated pathways can be beneficial in hmox-1 regulation.  The StREs 
serve as the binding sites for several transcription factors, of which Nrf-2 seems to be dominant.  
Likewise, the hmox-1 gene is activated by a variety of stress-associated agents; however, both 
systems are not responsive to the same inducer.  This flexibility in promoter binding and 
activation by various inducers allows regulation under more varied cellular conditions and via 
several mechanisms, thus increasing the combinatorial possibilities that determine the level of 
transcription.  Additionally, having two pathways allows for fine-tuning of the transcription 
response. Cooperation between the ERK1 and StRE can amplify the response, depending on the 
inducers and transcription factors involved. Also, these two pathways can serve as back-up 
systems so that if either of the Nrf-2 StRE pathways is inhibited, one of the transcription factors 
will still be able to respond and up-regulate partial HO-1 expression. Finally, under nonstress 
conditions, there are more options to use these transcription factors, for instance in cellular 
growth and development. 
In conclusion, these studies addressed the regulation of hmox-1 gene by two element 
transcription factors, Nrf-2 and StRE, in response to zinc.  Nrf-2 was shown to be a highly labile 
protein in response to oxidants such as zinc Evidences come from my results which show the 
cooperative role of the Nrf-2 and StRE, and as one more piece of evidence, whenever we 
mutated the StRE and or the ERK1, this had a profound negative impact on Nrf-2 induction. 
 How it escapes recognition and degradation by the ubiquitin-proteasome machinery and 
activates the hmox-1 gene needs to be investigated.   
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Analyses of the conserved motifs in the E1 enhancer led to the discovery of the well-
characterized StRE as an additional element (besides the Nrf-2) involved in zinc-induced hmox-1 
gene regulation.  Furthermore, the data presented suggests that both Nrf-2 and StRE function in a 
cooperative manner to activate the hmox-1 gene in response to zinc.  Establishing the cooperative 
role of both Nrf-2 and StRE in hmox-1 regulation will require further analysis, including 
examination of StRE and Nrf-2 deficient mice, as well as the interaction that occurs between 
these two transcription factors and the second pathway that involves the ERK1, which is 
activated in the presence of ROS. This leads, first, to its translocation to the nucleus where 
phosphorylation of the Nrf-2 occurs, and then to HO-1 gene induction. The identification of 
other factors involved in this mechanism is needed.   
Finally, a better understanding of why certain inducers use the StRE/Nrf-2 HSE/HSF-
1and ERK1-Nrf-2 pathway will help to establish the different mechanisms involved in hmox-1 
regulation and to provide important information on new avenues of research and strategies for 
therapeutic intervention and treatment in diseases involving oxidative stress and HO-1 
expression. 
On the basis of the data obtained in this study, the literature, previous studies with Nrf-2 
(Alam et al., 1999; Alam et al., 2000; He et al., 2001; Stewart et al., 2003), and speculation of 
plausible mechanisms of HO-1 activation by zinc, a model for hmox-1 gene activation by zinc in 
Hepa cells is proposed (Figure 4.1).  In unstimulated cells, Nrf-2 is a highly labile protein that 
binds to Keap1, which is rapidly and specifically translocated by the action of the ROS either in 
the cytoplasm or in the nucleus (Figure 3.5A), and by the action of the MAPKs (ERK1-1), Nrf-2 
is phosphorylated. The hmox-1 gene is either repressed or exhibits low levels of gene activity by 
StRE-binding proteins (StRE-BP).  Likely candidates for  repression include heterodimers 
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between StRE and Nrf-2.  Recent studies show that Bach1 and MafK each bind the hmox-1 
StREs, and targeted deletion of the bach1 gene results in increased constitutive expression of 
HO-1 mRNA and protein (Ogawa et al., 2001; Sun et al., 2002).  Whether there are repressor 
proteins at the HSE site is unknown.  Upon cellular stimulation, between Nrf-2 and Keap1, Nrf-2 
protein is released and translocates into the nucleus (Figure 4.1).  In the nucleus, Nrf-2, after 
phosphorylation, displaces StRE-BP repressors.  Likewise, zinc toxicity generates ROS, which 
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